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PREVENTING THYMUS INVOLUTION IN K5.Cyclin D1 TRANSGENIC MICE
SUSTAINS THE NAÏVE T CELL COMPARTMENT WITH AGE

Michelle Lynn Bolner, Ph.D. Candidate
Supervisory Professor: Ellen R. Richie, Ph.D.

The thymus maintains T cell receptor (TCR) repertoire diversity through perpetual
release of self-MHC restricted naive T cells. However, thymus involution during the
aging process reduces naïve T cell output, leading to defective immune
responsiveness to newly encountered antigens. We have found that early thymus
involution precipitates the age-associated shift favoring memory T cell dominancy in
young control mice. Furthermore, we have shown that age-related thymus involution
is prevented in mice expressing a keratin 5 promoter-driven Cyclin D1 (K5.D1)
transgene in thymic epithelial cells (TECs). Thymopoiesis occurs normally in K5.D1
transgenic thymi and sustains T cell output to prevent the age-associated decline of
naïve T cells in the periphery. We find that K5.D1 recent thymic emigrants (RTEs)
undergo typical phenotypic maturation. In addition, functional studies show that
K5.D1 peripheral T cells are responsive to anti-CD3 and anti-CD28 stimulation in
vitro. Competitive adoptive transfer studies with K5.D1 and nontransgenic RTEs
indicate that K5.D1 RTEs are incorporated into the peripheral T cell pool comparably
to nontransgenic controls. However, K5.D1 mature naïve (MN) T cells out-persist
control counterparts, which likely occurs, in part, to increased expression of the
cytokine receptor IL-7Rα. Collectively, these data show that preventing thymus
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involution not only sustains T cell output to maintain naïve T cell numbers, but also
provides functionally competent MN T cells during aging.
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CHAPTER ONE
INTRODUCTION & BACKGROUND

T cells mediate protective immune responses against infectious diseases and
cancer. T cells develop in the unique microenvironment of the thymus, where thymic
epithelial cells (TECs) provide essential cues for thymocyte differentiation and selection
to generate naïve T cells that are both self-MHC restricted and self-tolerant. A highly
diverse T cell receptor (TCR) repertoire in the peripheral T cell pool is essential to
generate immune responses against a vast array of antigens. To maintain TCR
diversity, the thymus continually produces and exports naive T cells to the T cell pool.
However, the thymus undergoes involution naturally with age and during severe stress.
This process is primarily due to degeneration of the TEC compartment. Reduced
thymopoiesis in the involuted thymus decreases the number of recent thymic emigrants
(RTEs) released to the peripheral T cell pool, which in turn restricts TCR diversity.
Contraction of the TCR repertoire increases susceptibility to infectious disease and
cancer (1). Furthermore, increased autoimmunity incidences during aging have been
linked to thymus involution, as degradation of the TEC compartment may allow selfreactive T cells to escape negative selection and compromise central tolerance (2).
While many groups have demonstrated that the extreme involution of the aged
thymus has severe consequences on thymocyte and peripheral T cell cellularity and
function, the potential consequences of early thymus involution have a been mostly
overlooked. Thymus cellularity in mice declines as early as 7 weeks of age. Previous
studies comparing thymocyte and peripheral T cells from young and old mice
considered mice young even if they were 3 or more months of age and therefore had
already undergone significant decline in thymus size (3-5). Hence, there is a gap in
1

knowledge regarding whether early thymus involution impacts the cellular composition
of the peripheral T cell pool in young adult mice. Therefore, the focus of this thesis is to
identify how early thymus involution influences the dynamics of peripheral T cell pool
subsets, and to determine whether preventing thymus involution may alter the
presence of these T cell populations.

1.1 The Thymus
The thymus is structurally complex. Anatomically, the thymus is composed of
two separate lobes that lie on either side of the body midline above the heart. Each
lobe contains functionally distinct outer cortex and inner medullary zones. Hematoxylin
and eosin (H&E) stained thymus sections show that the thymus is organized into outer
cortical and inner medullary regions (Figure 1A). The cortex, which is densely packed
with immature thymocytes, is stained dark blue by DNA-binding hematoxylin. The
medulla, however, contains fewer cells that take up less hematoxylin stain, allowing the
pink cytoplasmic eosin stain to be visible. Though the thymus is highly vascularized,
large vessels are present at the corticomedullary junction (CMJ) and serve as the site
of hematopoietic progenitor entry and emigration of mature T cells (6). The thymus also
contains a complex stromal microenvironment not visible by H&E stain consisting of
fibroblasts, endothelial cells, dendritic cells, macrophages and TECs. Stroma present
throughout the thymus provide essential instruction for developing thymocytes
(Reviewed in (7)).

1.1.1 Thymopoiesis
The production of T cells via thymopoiesis is a stringent process that is essential
for the maintenance of a broad TCR repertoire (For a schematic overview of
2
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Figure 1. Overview of thymus architecture and thymopoiesis.
(A) Overview of thymus organization, including cortex (dark stain), medulla (light stain),
subcapsule and corticomedullary junction (CMJ, magnification). (B) Schematic
representation of the stage of thymocyte development.
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thymopoiesis – see Figure 1B). Hematopoietic progenitors in adult bone marrow are
attracted to the thymus by chemokine gradients including CCL19, CCL21 and CCL25
expressed by TECs (8-10). Thymus-seeding progenitors continually migrate into the
thymic microenvironment and are thought to fill any available intrathymic niches to
sustain thymopoiesis (11). The most immature thymocytes lack the expression of CD4
and CD8 cell surface molecules and thus are referred to as double negative (DN)
thymocytes. DN thymocytes are further subdivided by the expression of the CD117,
CD44 and CD25 molecules to distinguish the first stages of T cell development (12).
The earliest DN thymocytes are not yet committed to the T cell lineage. In fact,
the primitive CD117+CD44+CD25- DN1 thymocytes retain the potential to differentiate
into multiple cell types, including the myeloid, NK and DC lineages (13). Therefore, very
specific signaling must occur in the cortex to support commitment to the T cell lineage
(14). To this end, deep cortical TECs express the Notch ligand Delta-like 4 (DLL4) that
promotes T lineage commitment (15, 16). The Dll4/Notch signaling pathway is crucial to
drive early thymocyte differentiation, and is thought to induce the maturation program
by gradually persuading T cell fate decisions through the activation of multiple
transcription factors (10, 17). In this way, Notch inhibits other cell fate potentials
including B cell, DC, lymphoid and myeloid lineages (18, 19). Disruption of Dll4/Notch
signaling during the ETP/DN1 stages drives cells instead toward a B cell lineage (20).
Thus the Notch signaling pathway, mediated by cTECs, critically influences cells
towards early T cell lineage commitment.
Thymocytes commit to the T cell lineage and initiate TCRβ gene rearrangement
during the DN2 (CD117+CD44+CD25+) developmental stage. While early DN2 cells that
express high levels of CD117 can be still diverted to the DC and NK lineages, this cell
fate potential narrows dramatically as cells initiate gene rearrangement of the β, γ and
5

δ chains of the TCR. Rearrangement of germ line DNA encoding each chain is driven
by the recombinase-activating (RAG) genes, and produces unique receptor sequences
to promote TCR diversity in thymocyte pool (RAG-mediated gene recombination is
outlined in (21)). Furthermore, the development of conventional αβ and rare γδ T cell
lineages bifurcate the DN2 stage ((22), reviewed in reference (23)), but for the
purposes of this thesis, we will focus on αβ T cell development. Upon completing the
DN2 stage by initiating β chain rearrangement, αβ thymocytes are subjected to multiple
stringent tests to become peripheral αβ T cells.
Successful rearrangement of the TCRβ chain is assessed during the DN3
(CD117-CD44-CD25+) developmental stage. TCRβ polypeptides are paired with the
invariant pre-TCRα (pTα) chain to form a pre-TCR. Successful extracellular expression
of this complex rescues thymocytes from programmed cell death via Lck/Fyn mediated
signaling (24, 25). Additionally, intracellular pre-TCR signaling permits continued
maturation to the short-lived DN4 (CD117-CD44-CD25-) stage, during which cells
undergo 8-9 rounds of proliferation, and initiate CD4 and CD8 expression to become
CD4+CD8+ double positive (DP) thymocytes (26).
Thymocytes that mature to the DP stage initiate TCRα gene rearrangement to
produce a functional TCR and receive positive selection signaling. In order for this to
occur, a second wave of RAG expression is initiated to drive TCRα gene
rearrangement, which continues until either positive selection signals extinguish
recombination or α chain rearrangement is exhausted. Polypeptide chains produced
from TCRα gene rearrangement displace the preTα chain to form αβTCRs. DP
thymocytes that do not generate functional TCRα gene rearrangements fail to express
αβTCRs and undergo apoptosis (death by neglect). However, those DP thymocytes
that do express αβTCRs are subject to positive selection, a process by which
6

thymocytes are tested for recognition of self-peptide in the context of MHC molecules.
Interactions between self-peptide MHC and TCRs on thymocytes provoke a goldilockslike scenario, such that thymocytes that react too strongly to self-peptide receive TCRmediated apoptosis signaling, while cells bearing nonresponsive TCRs undergo
programmed cell death (27). Only thymocytes with low to moderate binding affinity to
self-peptide in the context of MHC receive low, sustained TCR engagement that drives
RAS signaling to promote survival (Reviewed in (28)). Therefore, positive selection
ensures that thymocytes bear TCRs that are self-restricted. Because most DP
thymocytes express useless TCRs, only a small fraction (~10%) are positively selected
to upregulate the chemokine CCR7 to migrate into the medulla to become CD4 + or
CD8+ single positive (SP) thymocytes (29, 30).
Many different genes influence the SP thymocyte identity decision. For example,
the presence of ThPOK in the developing thymocytes helps direct T cell fate toward the
CD4+ lineage, whereas the absence of ThPOK redirects T cells to the CD8 lineage
(31). Recently, IL-7 and IL-15 signaling have also been implicated in specifying CD8 T
cell fate, as loss of these or the common cytokine receptor chain γ results in the
absence of SP CD8+ SP thymocytes in vivo (32). These results are consistent with the
kinetic signaling model proposed by the Singer group, in which the γc cytokines detect
the duration of TCR signaling that directs cell fate (33, 34). While there are still many
aspects of the cell fate choice to become CD4 or CD8 that remain unclear, positively
selected thymocytes do transition to the SP stage after down regulation of either CD4
or CD8 (34).
The last major hurdle of thymocyte development is necessary to impose central
tolerance by deleting auto-reactive cells from the repertoire that may promote
autoimmunity. Negative selection occurs primarily in the medulla and serves to delete
7

thymocytes bearing TCRs that strongly bind to self-antigen. Medullary thymic epithelial
cells (mTECs) promiscuously express tissue-restricted antigens (TRAs) that are
otherwise expressed elsewhere throughout the body, and both mTECs and DCs
present these self-antigens to SP thymocytes for sampling (35, 36). Thymocytes that
strongly recognize self-peptide are signaled through the TCR to undergo apoptosis,
thereby culling the population of potentially autoreactive clones (27). This negative
selection process is essential for establishing central tolerance, as systemic
autoimmunity occurs in mouse models where negative selection is averted (37, 38).
Importantly, CD4 thymocytes that have strong affinity for self-ligand can be diverted to
the regulatory T cell (Treg) lineage during negative selection, and serve to dampen the
peripheral immune response in particular contexts (39). Cells that survive β, positive
and negative selection may prepare for T cell exit from the thymus. However, these
essential checkpoints delete nearly 95% of cells before thymocyte development is
complete in order to ensure the production of only self-tolerant, self-restricted T cells.
The process of thymocyte selection and preparation for thymus exit can be
defined as multiple stages in CD4 SP thymocytes. Four subsets (SP1-4) identify the
transition from early stage TCR-auditioning thymocyte to the mature T cell poised for
thymic emigration. Early SP1 CD4 thymocytes mature from the DP subset and express
high levels of heat stable antigen (CD24) and C-type lectin CD69, indicative of TCR
engagement during positive selection (40). Positively selected cells then express the
CCR7 to migrate into the medulla to become SP2 CD4 thymocytes. During medullary
residency, thymocytes lose CD69 expression after completing negative selection,
identifying transition to the SP3 subset. Once CD69 expression is lost, transcription of
the sphingosine 1 phosphate receptor 1 (S1P1R) is initiated. This, along with Qa-2 and
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the re-expression of CCR7, identifies the late stage CD4 SP4 thymocytes prepared for
thymus emigration.
Exit from the thymus is the final step necessary to become a peripheral naïve T
cell. For the CD4+ and CD8+ SP cells that survive development, emigration is initiated
by the expression of genes under control of the transcription factor Kruppel-like factor 2
(KLF2) (41). KLF2 binds directly to the promoter of the G protein-coupled sphingosine 1
phosphate (S1P) receptor 1 (S1p1r) to drive expression. While all cells are believed to
produce S1P, pericytes lining the thymic vasculature create a S1P chemotactic
gradient that is strongest at the vasculature (42). Thymocytes bearing S1P1R follow
this increasing S1P gradient to the vessels to emigrate from the thymus (43, 44).
Interestingly, TCR engagement may act as a braking mechanism on thymus
emigration. Using a transgenic mouse model to drive expression of the C-type lectin
CD69, which is upregulated upon TCR signaling and binds to and induces S1P1R
internalization and retention of SP thymocytes in the thymus (45). Other studies have
shown that PI3K signaling exerts some control on thymus emigration, since SP
thymocytes are retained in the thymus during constitutive PI3K signaling (46).
Therefore, even the process of thymus emigration is regulated to ensure that
thymocytes undergo final maturation before being released to the periphery. Upon
successful exit through the perivascular spaces, emigrants escape the thymus through
the circulatory system and enter the peripheral T cell pool.

1.1.2 Thymus Stroma Overview
Though thymocytes constitute the major cell population within the thymus,
thymopoiesis relies upon interactions between thymocytes and the resident stroma to
produce functional, self-tolerant T cells. The thymic stromal cell compartment
9

encompasses a variety of cell types, including mesenchymal fibroblasts, endothelial
cells, TECs and hematopoietic-derived professional antigen presenting cells (APCs)
such as dendritic cells (DCs), macrophages and B cells (6). Each of these stromal cell
types provides an important component of the microenvironment. Thymic fibroblasts,
for example, create scaffolding for the organ by producing extracellular matrix (47).
Endothelial cells line the vasculature penetrating the lobes to regulate HSC entry and
naïve T cell emigration. DCs and TECs are indispensible for thymocyte development,
by providing thymocytes with essential microenvironmental niches that support survival
and T-lineage commitment as well as by presenting peptide/MHC complexes that
impose stringent TCR testing during positive and negative selection.

1.1.3 Thymic Epithelial Cells
Thymopoiesis depends on indispensable signals from the TEC-derived
microenvironment located throughout the thymus. TECs are present in a threedimensional network that is atypical compared to the stratified epithelium lining the
lumen of most organs. This unique epithelial orientation maximizes interactions
between thymocytes and TECs to promote cellular ‘crosstalk’ that sustains survival and
differentiation of both cell types. Additionally, the number and fitness of TECs directly
influences thymus size and the capacity for thymopoiesis through the availability of
niches promoting fate specification and survival signaling for developing thymocytes.
Thus, the capacity for thymopoiesis is unarguably linked to the condition of TECs
present in the thymus.
Distinct TEC subsets throughout the thymus promote specific stages of
thymocyte development. The cTEC subset, for instance, recruits bone marrow-derived
progenitors to seed the thymus by concerted expression of CCL19, CCL21 and CCL25,
10

and promotes early thymopoiesis by expressing IL-7 and Dll4 ligands for thymocyte
survival and T cell lineage commitment (15, 48, 49). Additionally, cTECs express the
unique proteosomal subunit β5t that permits self-antigen processing for positive
selection (50). Deletion of β5t results in the loss of CD8 SP thymocytes and reflects the
importance of this subunit for self-peptide processing for MHC class I loading during
positive selection (51). The mTEC subset, on the other hand, plays a central role in
negative selection of developing thymocytes. Mature mTECs express the transcription
factor Aire (Autoimmune regulator), which drives promiscuous expression of TRAs
normally found throughout the body. TRAs then are loaded onto MHC molecules and
presented on the cell surface for thymocyte sampling. Thymocytes that recognize TRAs
are either deleted from the thymocyte population or redirected towards the Treg
lineage. Without Aire expression, autoreactive thymocytes avoid cell death and
promote multiorgan autoimmunity (52). It is therefore imperative to maintain diverse
cortical and medullary TEC subsets for self-tolerant and self-restricted T cell
generation.
The TEC compartment originates from the endoderm of the 3rd pharyngeal
pouch during embryogenesis. The expression of transcription factor Foxn1 identifies
cells fated to become TECs in the pouch by mouse embryonic day 11.5 (6). Though
Foxn1 does not determine cell fate, expression is essential for differentiation and
maintenance of both embryonic and adult TECs, as evidenced by the arrest of TEC
development at the MTS24+ progenitor stage in Foxn1nu/nu mice (6, 53, 54).
Furthermore, embryonic TECs are the bipotent progenitors of both mTEC and cTEC
lineages during development (55, 56). Through complex interactions with the
surrounding mesenchyme and incoming lymphoid progenitors, the thymic anlage
develops cortical and medullary regions by late gestation that loosely resemble the
11

postnatal thymus. Many speculate that some TEC progenitor cells (TEPCs) may persist
past embryogenesis to maintain the postnatal TEC population.
In the adult thymus, the TEC population is far from quiescent. In fact, the half-life
of post-natal TECs is approximately 10-14 days, even in the involuting thymus (57).
There has long been speculation that a bipotent TEC progenitor cell (TEPC) must exist
to support such rapid cell replacement, and may reside at the corticomedullary junction
(58). Recently, two groups have independently identified progenitors in the thymus that
give rise to both cTECs and mTECs. The Chidgey group identified a Foxn1+ cTEC
subset that was capable of producing differentiated mTECs and cTECs in vivo (59).
The Kyewski group also identified a self-renewing, bipotent TEC progenitor (60). These
reports strongly suggest the existence of an adult thymic TEPC capable of producing
differentiated TECs. Furthermore, these studies suggest that sustaining functional
TEPCs may maintain the differentiated TEC environment to support continued
thymopoiesis beyond the normal involution timeframe.
TECs mature into multiple subsets that provide indispensible interactions with
developing thymocytes. Cortical and medullary TEC maturation stages may be
identified by the expression of multiple cell surface molecules (For overview, see Figure
2). Generally, maturation of both cTECs and mTECs is loosely defined by MHCII
expression, which increases as TECs mature from undifferentiated precursors to
mature, terminally differentiated TECs (61). Maturing cTECs also express the apoptotic
recognition receptor CD205 (61) and the glutamyl aminopepsidase marker Ly51.
Additionally, cTECs are the only known cell type that expresses thymoproteosomal
subunit β5t (51, 62). In mTECs, increased expression of the co-stimulatory molecule
CD80 is indicative of maturation (61, 63). Some MHCIIhi CD80+ mTECs further
differentiate to express AIRE for negative selection. Additionally, a maturation stage
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Figure 2. TEC Maturation in the post-natal thymus.
Both TEC lineages develop from a common bipotent progenitor. cTEC maturation is not
well defined, but cTECs can be identified by the expression of MHCII, CD205 and
Ly51. mTEC maturation progresses through an MHCIIloCD80lo expression stage to an
MHCIIhiCD80hi expression stage. Some mTECs further mature to the Aire+ stage, and
finally an Aire-Involucrin+ terminally differentiated stage.
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past Aire+ occurs, in which some TECs express the terminal indicator involucrin that is
expressed in mature skin epithelium. Skewing of any stages of TEC maturation
significantly impairs the quantity and quality of niches available for T cell development,
which reemphasizes the importance of maintaining the diverse TEC
microenvironments.
TECs and thymocytes engage in active bidirectional crosstalk that promotes
survival of both cell types. While it is understood that TEC subsets must be present for
thymocyte development to occur, the presence of thymocytes also promotes TEC
survival and differentiation. Perturbations of thymocyte development can critically
influence and even prevent the differentiation of TEC subsets. For instance, blocking
IL-7 signaling and TCRβ gene rearrangement through the use of RAG2/γc double
deficient mice arrests thymocyte development at or prior to the DN1 stage and results
in the blockade of TEC differentiation at a primitive K5+K8+ precursor stage (64).
Furthermore, the presence of DP thymocytes drives a cellular feedback mechanism to
regulate the amount of Dll4 expressed by CD40+MHCII+ cTECs to support ETPs (65).
Thymocyte-derived signals also directly influence mTEC differentiation. Arresting
thymocyte development at the DN3 stage by knocking out RAG expression impairs
mTEC differentiation and expansion (66). Deleting the TCRα locus or the downstream
signal transducer Zap-70 blocks thymocyte maturation at the DP thymocyte stage, and
the failure to generate SP thymocytes severely reduces mTEC numbers (67, 68). The
RANK signaling pathway also plays an important role in TEC proliferation. RANKL is
expressed by positively selected thymocytes and the receptor RANK is present on
medullary TECs. Mice harboring a mutation in either RANK or RANKL have fewer
mTECs and exhibit defective Aire+ mTEC development, whereas forced RANKL
expression restores the mTEC compartment in Tcra-/- mice (69, 70). Therefore,
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interactions with SP thymocytes are necessary for shaping the mTEC
microenvironment. Together, these studies demonstrate that blocking thymocyte
maturation at various stages affects TEC subset differentiation and reaffirms the extent
of interdependence between thymocytes and TECs.

1.2

Thymus Involution
The thymus is maximal in size and cellularity in young individuals, but undergoes

gradual and progressive involution with age. Declining thymus size is evident after just
one year of age in humans (71). In mice, reduced thymus cellularity and T cell output
occurs by 6-7 weeks of age (6, 72). While the exact driving forces behind thymus
involution are still a matter of debate, involution accelerates after puberty and drives
disorganization of the thymic architecture (Reviewed in (6, 73)). Severe thymic
involution is evident in both aged mice and elderly patients, which significantly restricts
thymopoiesis necessary for supporting peripheral naïve TCR diversity (1, 74). Naïve T
cell numbers decline and promote the homeostatic proliferation of existing peripheral T
cells as a consequence of involution. These peripheral T cell pool dynamics lead to
increased susceptibility to disease and poor viral clearance (75). Additionally, poor
memory formation occurs after vaccination of aged individuals and stems from
diminished naïve TCR repertoire diversity, rendering them vulnerable to preventable
infectious diseases (76). Thus, deterioration of the thymic microenvironment spurs
immune dysfunction in the peripheral T cell pool.

1.2.1 Stromal changes during thymic involution
Thymus involution profoundly impacts the cortical and medullary
microenvironments. Declining cellularity and cortical thinning are initiated during early
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involution, whereas disorganization of the thymic architecture and the accumulation of
adipocytes in and around the thymus are present in advanced involution (6).
Furthermore, the representation of stromal cell subsets is altered as a consequence of
involution: TEC numbers from one-year-old mice are half that found in one-month-old
mice (57). Additionally, the mTEC:cTEC ratio declines substantially during involution,
whereas the frequency of other stromal components including fibroblasts significantly
increases from one month to one year of age (57, 77). Thus, involution disrupts the
balance of essential infrastructure components in the thymic microenvironment.
Degeneration of the TEC compartment is the major physiological alteration that
drives declined size and thymopoiesis in involuting thymi. Transferring ETPs from
young mice into aged mice cannot restore thymopoiesis or thymic size (78). However,
fetal thymi implanted under the kidney capsule of old recipients are efficiently colonized
by aged bone marrow progenitors (79). These reports suggest that the impaired ability
of aged thymi to support thymopoiesis stems primarily from stromal defects and not
from thymus-seeding progenitors. Furthermore, TEC cellularity in aged (1yr old) mice
reflects only a third of the cellularity present in one-month-old mice (57). This cellular
loss drastically reduces the quantity of niches available to support thymopoiesis.
Moreover, the complexity of the remaining microenvironments are compromised with
involution: TECs expressing high levels of MHCII are lost as the organ atrophies and
skews the TEC subsets present in aged thymi (57). These results, coupled with
athymia of the Foxn1 nude mouse strongly suggest that the impairment of
thymopoiesis occurs from degenerating TEC populations.
Maintenance of the TEC compartment is dysregulated during the involution
process and is thought to stem from downregulation of Foxn1 (80, 81). Studies using a
hypo-allelic scheme for Foxn1 expression show that it is required for the maintenance
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of TEC subsets supporting T cell development (81). To this end, over-expressing
Foxn1 does maintain TEC numbers and slows the progression of involution, though it
does not cease it completely (82). This suggests other factors must circumvent Foxn1
to drive thymus involution. However, re-expression of Foxn1 after thymus involution
can promote thymus maintenance and regeneration in a TEC-mediated manner. In
fact, studies in which Foxn1 expression was maintained or re-expressed in severely
involuted thymi showed both an increase in proliferation and differentiation of TECs
(83, 84). Therefore, the aged TEC population retains some regenerative potential in the
involuted thymus, through the expression of Foxn1.
The thymic microenvironment is not only altered by the loss of TECs but also by
the presence of adipocytes. While the origin of these cells has not been defined,
speculation in the literature suggests that adipocytes may be derived from epithelial-tomesenchymal transition (EMT) (6, 85). Adipocytes appear and increase with the
progression of thymus involution, and may alter the cytokine milieu for thymopoiesis.
Many cytokines, including leukemia inhibitory factor, stem cell factor, IL-15 and IL-6,
can induce thymic atrophy, and are elevated in naturally involuted thymi (86).
Interestingly, adipocytes present in involuted thymi have been shown to express these
same cytokines, suggesting that adipocyte presence may influence the cytokine milieu
and promote involution (86). Furthermore, reports have correlated obesity and calorie
restriction to thymic function, in such a manner that obesity promotes thymus
involution, whereas calorie restriction improves T cell output and maintenance of thymic
architecture (87, 88). Therefore, alterations in the composition of the microenvironment
itself may alter the cytokine profile that impairs thymopoiesis.
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1.2.2 Thymus regeneration
It is well understood that thymus size is plastic, even after involution. In fact, as
early as the turn of the early 20th century castration in cattle was known to increase
thymus size (89). Because severe infection, stress and lymphoablative therapy damage
the immune system and cause severe thymus involution, thymus regeneration has
been looked to as a potential therapy for rebuilding the T cell pool. Thymus cellularity
and T cell output are readily rebounded by treatments such as sex steroid ablation
(SSA) and administration of keratinocyte growth factor (KGF), both of which drive TEC
proliferation. Additionally, these treatments can increase T cell output in both rodents
and humans with severely involuted thymi. SSA has been shown to enhance cytotoxic
T lymphocyte-mediated viral clearance by increasing naïve CD8 T cell numbers in the
periphery (90). Much like SSA, KGF has also proven to be a reliable tool for thymic
rebound and increased T cell production. Administration of KGF in mice leads to
increased proliferation and higher total TEC numbers (91, 92). Furthermore, the KGF
receptor fibroblast growth factor receptor 2 IIIb (FGFR2IIIb) is expressed on TECs and
promotes expansion of the microenvironmental niches that support ETPs and
thymocyte development (93). These therapies hold potential for rebuilding the
peripheral T cell pool after episodes of severe damage.
While SSA and KGF treatments increase TEC number and improve the volume
of T cell production, the effects are temporary and thymus involution will reoccur after
withdrawal. Additionally, strategies to rebound thymus size may improve T cell
production but do not yield complex thymic microenvironments necessary for
appropriate T cell selection. Recently, the Petrie group showed that medullary
complexity and the expression of tissue-restricted antigens (TRA) are negatively
altered with age (94). Global gene expression analysis from stromal cells of castrated
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12 month old mice and young mice showed that while the size and T cell output
increases after castration, the expression of many TRA remain similar to aged, noncastrated sham mice. In fact, no statistical differences were found between TRA
expression in castrated versus sham treated mice at 12 months of age, indicating that
thymus regeneration may increase cell numbers but cannot rescue the degenerative
TEC function that is driven by involution (94). These data also suggests that thymus
regeneration may produce T cells capable of skewed, potentially autoreactive
responses. Thus, an aged thymus regenerated by various means is not functionally
equivalent to a young, non-involuted thymus with regards to producing self-tolerant T
cells.

1.3

Peripheral T cells
The peripheral T pool contains functionally and phenotypically distinct T cell

subsets, each expressing a diverse TCR repertoire. Such diversity promotes the
generation of effective immune responses to a vast array of antigens. Each T cell clone
expresses a unique TCR resulting from TCRα and TCRβ gene rearrangements during
thymocyte development. In fact, there are up to 1011 unique clones in young adult
humans and nearly 108 unique TCR clones in mice (95). However, this diversity
declines with age and continued antigen experience, reducing the diversity of
peripheral T cells and allowing holes to develop in the TCR repertoire. Therefore
investigations focused on rebuilding or sustaining TCR diversity are an important
avenue for maintaining a diverse peripheral TCR population.
The T cell pool is comprised of both CD8+ cytotoxic and CD4+ T helper cells.
CD8+ cytotoxic T cells serve as the infantry of the T cell response by mediating cell
death of infected cells while sparing ‘innocent bystander’ cells. All CD8 + T cells
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differentiate to an effector status after activation, and can transfer cytolytic granules to
target cells after TCR activation or induce Fas signaling to prompt apoptosis.
Furthermore, CD8+ T cells release cytokines such as TNFα and IFNγ to promote
antimicrobial defenses and additional immune cell recruitment. In contrast, CD4 + T
helper cells constitute a heterogeneous collection of cells that provide help against
particular types of pathogens. A single CD4+ T helper clone can produce daughter cells
that may be polarized toward different lineages including the Th 1, Th2, Th3, Th17, ThFH
and Treg lineages (Reviewed in (96)). The Th1 subset promotes anti-bacterial responses
in infected macrophages by producing IFNγ for macrophage activation, whereas the
Th2 subset primarily secretes cytokines to recruit mast cells, eosinophils and plasma
cells that combat parasitic infections (97). Th17 T cells play an important role during
early stages of the adaptive immune response against bacteria and fungal infections by
promoting neutrophil responses (98). Recently, the ThFH T cell subset was identified
and shown to help activate B cells in the follicular zone of the lymph nodes (99). In
contrast to the other subsets of T helper cells, Treg cells perform the important role of
suppressing the activation and proliferation of nearby T cells to prevent an autoimmune
response (100). Many Treg are derived from thymocyte clones that react strongly to selfantigen during the positive selection stage of thymocyte development, therefore
rendering them prime candidates to recognize T cells and dampen the immune
response (101). Impressively, the polarization of CD4+ T helper cells is heavily
influenced by the cytokine milieu in the infection area. For instance, Th 1 T cells secrete
IFNγ that promotes the polarization of surrounding T cells toward the Th 1 lineage,
whereas Th2 T cells produce IL-4 to support differentiation of other T cells to the Th2
subset. In this manner, first-responding cells can dictate the type of immune response
necessary to clear the infection.
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Within each T cell subset, cells are loosely defined by experience: those that
have not yet encountered cognate antigen are considered naïve, whereas T cells that
persist after responding to antigen are referred to as memory T cells. Naïve and
memory T cells produce distinct responses to infection that play equally important roles
in the immune response. Naïve T cells are activated and generate effector cells over
the course of a few weeks in response to new antigens presented by APCs. Memory T
cells, on the other hand, rapidly clear reinfection in a matter of days. Naïve and
memory T cells are identified by the expression of molecules necessary for migration
and activation. Naïve T cells circulate through the vasculature and enter lymph nodes
to interact with APCs. To permit this movement, naïve T cells express L-selectin
(CD62L) to promote diapedesis, as well as the chemokine receptor CCR7 that
recognizes the chemokine gradient directing cells towards the lymph nodes (102, 103).
Expression of the early activation marker CD69 and the adhesion marker CD44 occur
as naïve T cells are activated by APCs to initiate an immune response. Once the
immune response is resolved, the majority of activated T cells die, leaving CD69 -CD44+
memory T cells behind to serve guard to potential reinfection (104).

1.3.1 T cell homeostasis and the influence of thymus involution
The peripheral T cell pool is maintained at a relatively constant number by RTE
contribution from the thymus as well as homeostatic proliferation of existing peripheral
T cells. All cells in the periphery require interaction with survival factors in order to
persist. Naïve T cells require signaling via IL-7 and MHCII, whereas memory T cells
require IL-7 and IL-15 signaling to permit homeostasis (105-108). In steady state
conditions homeostatic signaling promotes survival, whereas in times of lymphopenia
the same signaling promotes clonal proliferation (Reviewed in (109, 110)). In this way,
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peripheral T cell numbers remain relatively stable throughout life. However, the
frequency of naïve and memory T cells does change significantly during normal aging
or after various stresses including viral infection, cytoablative therapy and pregnancy.
In normal, healthy individuals, progressive thymus involution slowly restricts T cell
production. As decreasing RTE numbers fail to sustain the size of the naïve T cell pool,
the naïve T cell numbers decline, resulting in slight lymphopenia. The T cell pool
compensates for this cellular loss by promoting proliferation of all cells until total
cellularity is restored. Consequently, the ratio of naïve and memory T cells shift in such
a way that naïve T cell frequency is diminished while memory T cell frequency
becomes predominant, and grows more severe with age to restrict TCR repertoire
diversity. Furthermore, ‘holes’ develop in the TCR repertoire that can be exploited by
infection. Therefore, severe thymus involution precipitates the age-associated changes
affecting immune responses of the peripheral T cell pool (109).
The function of the T cell pool as a whole declines as a result of aging. While
thymus involution diminishes the rate of peripheral T cell replacement, it permits the
accumulation of long-lived naïve T cells. Additionally, naïve T cell proliferation
increases to maintain cell numbers, and drives exhaustion of the existing cells that
promotes sub-optimal IFNγ production upon activation and inadequate helper T cell
functions (111). Many aging CD8+ naïve T cells transition to the CD44+CD62L+ virtual
memory (VM) phenotype, further skewing the frequency of T cell populations. While VM
cells are more responsive to cognate antigen, these cells proliferate less upon TCR
stimulation compared to new naïve T cells, which correlates with higher levels of
apoptosis upon encountering peptide (112). Ultimately, with functional defects and
declining TCR repertoire diversity, holes develop in the immune response for antigens
the T cell pool can no longer recognize (1). Therefore, losing recent thymic emigrants
23

via thymic involution is likely the catalyst behind T cell population dynamics and
diminished immune responses with age.

1.3.2 Recent thymic emigrants are phenotypically and functionally distinct naïve T cells
It is no surprise that the T cell pool relies heavily on RTEs. Not only do RTEs
maintain the diversity of the adult naïve T cell pool, they also establish the peripheral T
cell pool in neonates and play a fundamental role rebounding naïve T cell numbers
after infection- and stress-induced lymphopenia (113). The rate of RTE release is
relatively constant throughout life and calculated at 1-2% of thymocytes per day, yet the
reduction in thymopoiesis from thymus involution severely restricts the number of RTEs
produced with age (72, 114). Declining RTE contribution to the peripheral T cell pool
drives TCR diversity restriction, increases susceptibility to infectious diseases and
reduces vaccination efficacy. Therefore, it has been suggested that maintaining the
number of RTE in the peripheral T cell pool is vital to sustaining a naïve T cell
population that generates robust immune responses.
RTEs are both phenotypically and functionally distinct from the mature naive
(MN) T cells that they mature into during the first few weeks of peripheral residency.
During this transition period, RTEs alter expression of cell surface molecules respond
to survival factors and cognate antigens ((115), Reviewed in (116, 117)). RTEs do not
compete as well as MN T cells for homeostatic signaling in a lymphoreplete
environment due to low-level expression of IL-7Rα and must overcome this expression
deficit in order to persist in the peripheral T cell pool (118). Additionally, RTEs that are
subjected to TCR-stimulation exhibit diminished activation (Discussed in section 1.3.4).
While the molecular basis for extra-thymic maturation is not yet fully elucidated, some
evidence suggests that promoter methylation of interleukin genes and the tuning of cell
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surface molecules does not occur until after thymocytes complete thymus emigration
(115, 119). Furthermore, RTEs must immigrate into secondary lymphoid organs in
order for the RTEs to transition to MN T cells, supporting the hypothesis that cell
extrinsic factors drive RTE maturation (120). TCR repertoire changes from the RTE to
MN T cell stage suggests that another facet of RTE maturation may involve pruning the
TCR repertoire of RTEs before incorporation into the MN T cell population (121). Thus,
extra-thymic RTE maturation is critical for new naïve T cells to persist in the naïve
subset of the peripheral T cell pool.

1.3.3. Advances in RTE identification
Identification of RTEs in the past was nearly impossible, as no known cell
surface molecules exist to differentiate RTEs from MN T cells in mice and humans.
Previous methods of identification relied on TCR excision circles (TRECs), which are a
product of RAG-mediated TCR gene rearrangement during thymopoiesis (122).
However, the number of TRECs in an RTE are finite and are not inherited equally
between daughter cells, which can allow some RTEs to be misidentified as MN T cells
(116). Furthermore, visualizing TRECs requires cell fixation due to their intracellular
nature, and this process is not permissive for functional analyses of RTEs. Another
RTE identification method utilized intrathymic FITC injections to label thymocytes. As a
result, T cells that emigrate after the FITC injection can be identified in the periphery as
FITC+ cells (123). This method is both physically traumatic to the animal and demands
short-term analysis, as cells only retain FITC labeling for a few days. Another major
drawback to FITC injections is that this method labels all thymic cells including
peripheral T cells that recirculate into the thymus and exit again during the
experimental timeframe (116).
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Recently, another approach has been taken which unambiguously identifies
RTEs, in a manner that does not impact the health of the animal and allows for
downstream manipulation of RTEs and MN T cells. The Nussenzweig lab generated
mice expressing a GFP transgene under control of the RAG2 promoter (RAG2-pGFP)
as reporters of Rag2 expression (124). The RAG2 gene is a faithful reporter of VDJ
gene rearrangement in both B and T cells. Since TCR gene rearrangement only occurs
during thymocyte development and is silenced thereafter, this transgene provides
robust GFP labeling of all RTEs that migrate to the periphery. The GFP label half-life is
16-18hrs, which allows GFP expression to be used as a molecular clock to distinguish
RTEs that have resided in the periphery for less than a week (GFP hi) from RTEs that
have resided in the periphery for one to three weeks (GFPlo). Importantly, RTEs can be
discriminated from the phenotypically and functionally distinct MN T cells that
emigrated from the thymus 3 or more weeks prior to the analysis (115).

1.3.4 RTE maturation and function
Maturation in the periphery must occur for RTEs to develop into functionally
mature naïve T cells. The transition of RTEs to MN T cell status is characterized by the
altered expression pattern of cell surface molecules important for optimal TCR
interaction and signaling (116). Changes in expression of surface markers indicative of
RTE to MN transition are summarized in Figure 3. TCR expression decreases during
RTE maturation to ensure that only high affinity interactions with cognate antigen drive
T cell activation (116). The expression of the co-stimulatory molecule CD28 increases
during transition to MN T cells promote TCR signaling (115). Also, IL-7 receptor is
essential for T cell persistence in the periphery, and is upregulated as RTEs mature
(115).Expression of CD45RB, an isoform of the TCR accessory molecule CD45, is
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Figure 3. RTE maturation is defined by phenotypic changes in cell surface
expression.
Transition from RTE to MN T cell is accompanied by the upregulation of IL-7Rα, CD28,
Qa-2, and CD45RB, as well as the downregulation of CD24.
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upregulated as RTEs transition to MN T cells (116). Additionally, other molecules are
fine tuned during the RTE maturational program. Heat stable antigen (CD24), which is
required for optimal homeostatic proliferation of naïve T cells, is downregulated during
RTE maturation (116, 125). Qa-2, a non-classical MHC I molecule expressed on most
T cells is up regulated during RTE maturation (126). Optimizing the expression of
certain molecules during RTE maturation is necessary to persist long term in the
peripheral T cell pool and produce robust responses upon activation.
RTE maturation cannot occur without entry into secondary lymphoid organs
(SLO), as failure to access lymphoid tissues blocks RTE maturation and causes
programmed cell death (120). CD8+ RTEs preferentially home to the gut-associated
lymphoid tissues (GALT), which suggests that RTEs play a role in immune responses
at mucosal surfaces, which may also promote tolerance to communal bacteria (127).
Importantly, the presence of DCs in lymph nodes is necessary to facilitate RTE
maturation. While the exact molecular signaling between DCs and RTEs is currently
unknown, RTE maturation is stalled when DCs are deleted in vivo (128). DCs and the
SLO microenvironment provide important homeostatic signals including IL-7 and MHCII
expression, which have been investigated as potential means to facilitate RTE
maturation. However, neither MHCII nor IL-7 availability is necessary for RTEs to
transition to MN T cells. In fact, RTEs can persist without these homeostatic molecules
during the first few weeks of peripheral residency (121, 128). Therefore, some unique
but unidentified function of DCs and the microenvironment are crucial for RTE
maturation.
While RTEs can be activated by TCR signaling during maturation, they are less
immunocompetent than MN T cells. RTEs stimulated with anti-CD3 in culture proliferate
less than their MN counterparts (115). Furthermore, CD8+ RTEs produce fewer effector
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T cells upon activation, and of those effector cells, fewer produce TNFα (129). CD8
RTEs also produce lower amounts of cytokines such as IL-2 and IFNγ and this
functional deficiency persists up to 60 days after infection (130). Recently, CD8+ RTEs
were reported to produce stronger TCR signaling transduction from low-affinity ligands
than MN T cells, and to be more capable of efficiently entering inflamed tissues by
expressing high levels of VLA-4 (131). Functional differences between CD4+ RTEs and
MN T cells have also been described. TCR signaling during RTE maturation skews
CD4+ T cells away from Th1 effector lineage and toward Th2 effector lineage (132).
Together, these results suggest that RTEs may respond differently than MN T cells to
activation to 1) minimize the impact of activation before being deleted or tolerized to
self- or symbiotic- antigen, or 2) supplement existing MN T cell responses during
infection.

1.3.5 Effects of aging on RTEs
Age and involution significantly impact the numbers, maturation and function of
RTEs. While RTEs are still produced well into old age, RTE numbers in mice decline
dramatically by six months of age as a result of thymus involution (72). Furthermore,
delayed RTE maturation kinetics can be observed in mice only a year old, such as
delayed CD24 downregulation during transition to MN T cell status (72). Mice aged to
16-24 months old have RTEs exhibit significant functional defects, in including less IL-2
secretion, lower proliferation and defective calcium release upon stimulation in vitro
(72, 133). Both aging ETPs and the degenerating TEC compartment have been
implicated as potential sources for delayed RTE maturation and aberrant
responsiveness observed in RTEs from older mice (134). These finding suggests that
thymus involution not only restricts RTE numbers but may influence extra-thymic
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maturation and function of these cells once released from the degenerating thymic
microenvironment. More investigation is warranted to determine the extent of influence
the thymic microenvironment has on RTE activity in the periphery. How the severe
decline in RTEs during the first six months of life impacts the phenotypic and functional
changes observed in aged mice is currently unknown. Furthermore, it is not clear if
maintaining thymus output can ameliorate the phenotypic differences of older mice.
Therefore, we will employ the K5.D1 transgene to investigate how preventing thymus
involution impacts RTE output and response to TCR stimulation.

1.4

Thymus involution does not occur in K5.Cyclin D1 transgenic mice
Our lab has previously shown that driving overexpression of a Cyclin D1

transgene by a keratin 5 promoter prevents thymus involution (135, 136). While Cyclin
D1 is well known for its role as a cell cycle progression protein, it also forms physical
associates with more than 30 transcriptional regulators (137). The K5.Cyclin D1
transgenic mouse model exhibits increased thymocyte cellularity with age and does not
undergo thymus involution. Pathological studies have found no indication of thymoma
or lymphoma. Instead, the K5 Cyclin D1 transgene drives increasing TEC cellularity
with age without dysregulating the medullary and cortical architecture (135). Therefore,
the microenvironmental niches are expanded in these transgenic mice, making the
increase in thymocyte cellularity secondary to the increase in TEC number.
Additionally, driving TEC expansion may increase the number of niches available for
early thymocytes. The major thymocyte subsets are intact in the K5.Cyclin D1 model,
suggesting that normal thymopoiesis occurs, and normal peripheral frequencies of CD4
and CD8 T cells support this data. Therefore, this model serves as a suitable tool for
determining how preventing thymus involution affects T cell output with age.
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Many have suggested that preventing thymus involution should sustain T cell
output and maintain a diverse TCR repertoire for immune responses. However, little
investigation has been done to determine how the process of thymus involution affects
the peripheral T cell populations of young mice. Therefore, the focus of this thesis is
two-fold: first, the impact of thymus involution on the existing T cell pool will be
identified, and second, we will determine how preventing thymus involution using the
K5.D1 mouse model alters these peripheral changes. Because the K5.D1 mouse
model provides an opportunity to study both TEC maintenance and thymopoiesis
without the constraint of involution and that influence the peripheral T cell pool, the
Results section will be separated into two chapters. First, we will identify the thymic
K5.D1 phenotype (Chapter Three) followed by its influence in the peripheral T cell pool
(Chapter Four).
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CHAPTER TWO
MATERIALS & METHODS

Mice
Mice carrying the K5.CyclinD1 (K5.D1) transgenic were originally generated by
C. Conti (MD Anderson Cancer Center, Science Park Research Division, Smithville,
Texas) and maintained on the C57Bl6/J background in the Richie lab. RAG2p-GFP
transgenic mice on the CD45.1 and CD45.2 C57Bl6/J congenic backgrounds were
gifted from P. Fink (University of Washington) and crossed to the K5. D1 model to
obtain K5.D1;RAG2p-GFP double transgenic mice. PCR was utilized to determine
K5.D1 and RAG2p-GFP transgene expression, and GFP expression was confirmed
visually in the thymus upon dissection by fluorescence microscope (Olympus Provis
AX70). Female Nur77-GFP mice were gifted from L. Ehrlich and crossed to
K5.CyclinD1 males for TCR engagement studies. F1 congenic CD45.1+;CD45.2+
heterozygous C57Bl6/J recipients of adoptive transfer experimental injections were
bred in house by crossing C57Bl6/J CD45.2 females to C57Bl6/J CD45.1 males. All
mice were maintained in pathogen-free conditions, and experiments were performed in
accordance with all MD Anderson Institutional Animal Care and Use Committee
policies.

Tissue preparation for lymphocyte FACS analysis
Thymus, spleen, axillary and inguinal lymph nodes were removed and placed in
cold, sterile 1x PBS (Hyclone). Organs were trimmed of connective tissues and
pressed through a 70μm mesh strainer (Fisher) using the plunger from a 3ml syringe
(BD Falcon). Strainers containing tissue were washed with FACS Wash Buffer (5mM
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EDTA pH8, 2% FCS) and collected in a 50ml conical tube (BD Falcon). Conical tubes
were then centrifuged at 1500rpm for 6 minutes to pellet cells. Cells were treated with
RBC Lysis Buffer for 5min at room temperature, then diluted with 10ml FACS Wash
Buffer and centrifuged at 1500rpm for 6 minutes to pellet cells. Cell pellets were
resuspended in 10ml cold FACS Wash Buffer. Single cell tissue preparations were
counted using trypan blue viability stain (Life Technologies) by a Countess® automated
cell counter (Life Technologies) or by haemocytometer. Cells were distributed at a
concentration of 3 million cells per FACS polystyrene tube (BD Falcon) in 300ul of
FACS Wash Buffer for antibody staining.

Tissue preparation for thymic epithelial cell FACS analysis
Thymic tissue was excised from the thoracic cavity, places in cold, sterile 1x
PBS (Hyclone) and trimmed of connective tissues. Lobes were separated, and 4-5
small nicks were made about 2-3mm into each lobe. For some experiments
collagenase followed by collagenase/dispase was used to digest lobes as previously
described (138), whereas in later experiments liberase was utilized to dissociate TECs
as previously described (139). After the final digestion, enzymes were quenched with
up to 50ml ice-cold FACS Wash Buffer, centrifuged to pellet cells. Cell pellets were
resuspended to 10ml in FACS Wash Buffer, filtered by passing through a 70μm mesh
strainer (Fisher) and counted using Trypan Blue (Life Technologies) on an automated
cell counter (Life Technologies). Cells were distributed at a concentration of 3 million
cells per FACS polystyrene tube (BD Falcon) in 300ul of FACS Wash Buffer for
antibody staining.
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Antibodies used for FACS analysis
Single cell suspensions were stained with combinations of the following
antibodies: anti-CD3-BV450, anti-CD4-Alexafluor 780, anti-CD5-Pacific Blue, anti-CD8PE/Cy7, anti-CD11b-PE/Cy5, anti-CD11c-PE/Cy5, anti-CD24-PerCP/Cy5.5, anti-CD25A488, anti-CD44-APC, anti-CD45-PerCP/Cy5.5, anti-CD45.1-Pacific Blue, anti-CD45.2PE, anti-CD45RB-Pacific Blue, anti-CD62L-PE or anti-CD62L-Alexafluor 700, antiCD69-PE, αβTCR-Alexa 700, anti-ckit-APC/Cy7, anti-γδ-TCR-PE, anti-TER119PE/Cy5, anti-CD127-Biotin (eBioscience), anti-IA/IE-Pacific Blue (BioLegend), antiUEA1-FITC (Vector), anti-Ly51-Biotin, anti-Qa-2-Biotin, and anti-Mouse IgG2a,k-Biotin
(BD Pharmingen/BD Biosciences). Primary antibodies were added to 3 million cells
suspended in 300ul PBS on ice for 15 minutes in the dark, and washed with up to 3ml
cold FACS Wash Buffer. Samples were centrifuged at 1500rpm for 3 minutes to form
cell pellets. Supernatant was removed and cell pellets were resuspended in 300ul of
PBS. The secondary antibody SA-Qdot 605 or SA-Qdot655 (Life Technologies) was
used to visualize streptavidin-labeled antibodies by incubating for 15 minutes in the
dark on ice. Samples were again centrifuged at 1500rpm for 3 minutes to pellet cells,
supernatant was removed and cell pellets were resuspended. For intracellular staining,
antibodies including anti-Bcl2-PE and anti-Foxp3-APC were utilized and cells were
incubated 30 min in the dark at room temperature. All samples were brought to a
volume of 400ul in PBS for FACS analysis using the AriaIIu or Fusion cell sorters,
or Fortessa® cell analyzer (BD Biosciences). Acquired data was analyzed using the
FlowJo (Versions 9.6.10-9.7.4) program by Treestar (Ashland, Oregon).
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BrdU analysis
BrdU labeling to determine T cell proliferation was performed by a single i.p.
injection of 100μl of BrdU (10mg/ml, BD Biosciences) into adult mice, followed by
feeding 0.8mg/ml BrdU water with 0.1% sucrose for 8 days. On the eighth day, mice
were sacrificed for flow cytometric analysis. BrdU labeling to determine thymocyte
proliferation was performed by a single i.p. injection of 100μl of BrdU (10mg/ml, BD
Biosciences) into adult mice, which were sacrificed 16 hours later for flow cytometric
analysis. For flow cytometry staining, the BrdU staining protocol (BD Biosciences)
included in the kit was followed, and either FITC or APC conjugated anti-BrdU was
used to visualize intracellular BrdU labeling.

Foxp3 analysis
Extracellular staining of single cell suspensions was performed with antibodies
described previously. Cells were then fixed using the Foxp3 (eBioscience) kit and
stained with Foxp3-APC antibody according to the kit directions, and analyzed on a
FACS Fortessa cell analyzer.

Vβ TCR Repertoire Analysis
Vβ repertoire analysis was performed using the TCR Vβ Screening Panel (BD
Biosciences), in combination with additional fluorochromes mentioned previously. All
repertoire analysis was performed on a FACS Fortessa cell analyzer.

Splenic T cell sorting
Single cell suspensions of splenic T cells from RAG2p-GFP and
K5.CyclinD1;RAG2p-GFP congenically marked mice were enriched for CD4 and CD8 T
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cells by MACS separation (Miltenyi Biotec) using the CD4+ enrichment kit II (Miltenyi
Biotec, cat # 130-095-248) and the ‘depletion protocol’. In other experiments, T cells
were enriched by incubating freshly isolated splenocytes with purified antibodies
against CD11b, CD11c, B220 and TER119 for 30 minutes on ice, followed by two
10min incubations with Sheep anti-rat IgG Dynal beads (Life Technologies) on a rotator
at room temperature, and applied to a magnetic field. Supernatant was removed, then
washed and stained as described above. Cells were sorted on a FACSAria IIu or
Fusion cell sorter for Lin-CD8-CD44-GFP+, Lin- CD8-CD44-GFP- subsets directly into
5ml polysterene tubes containing FCS or microcentrifuge tubes containing 800ul TriZol.
Live cells in FCS were pelleted by centrifugation for 3min at 1500rpm. Supernatants
were removed and cell pellets were resuspended in 100ul PBS, counted by using
trypan blue viability stain by a Countess® automated cell counter.

Adoptive transfer of sorted T cells into lymphoreplete recipients
CD4+ RTEs and MN T cells were sorted from isolated splenocytes as described
above. Cells were pelleted by centrifugation at 1500rpm for 3 minutes, supernatant
removed and resuspended less than 200ul of PBS. Cells were counted using trypan
blue viability stain (Life Technologies) and a Countess® automated cell counter (Life
Technologies). To compare the persistence of cells of interest, adoptive transfers of
RTEs and MN T cells at a 1:1 ratio was performed by retro orbital sinus injection of
anesthetized 10-14wk old F1 CD45.1+;CD45.2+ congenic WT or K5.D1 transgenic
recipients. Input ratios were obtained by staining an aliquot of the mixed cell
suspension with CD45.1-PE and CD45.2-PacBlue (eBiosciences) and analyzed by flow
cytometry.
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Analysis of lymphoreplete adoptive transfer experiments
Recipient mice were sacrificed at 1, 3 or 6 weeks after adoptive transfer, and
spleen, axial and inguinal lymph nodes were dissected and washed in ice-cold PBS.
Organs were trimmed of connective tissues and pressed through a 70μm mesh strainer
(Fisher) using the plunger from a 3ml syringe (BD Falcon). Strainers containing tissue
were washed with FACS Wash Buffer (5mM EDTA pH8, 2% FCS) and collected in a
50ml conical tube (BD Falcon). Conical tubes were then centrifuged at 1500rpm for 6
minutes to pellet cells; cell pellets were resuspended in 10ml cold FACS Wash Buffer.
Single cell tissue preparations were counted using trypan blue viability stain (Life
Technologies) by a Countess® automated cell counter (Life Technologies) or by
haemocytometer. Cells were distributed at a concentration of 3 million cells per FACS
polystyrene tube (BD Falcon) in 300ul of FACS Wash Buffer for antibody staining. Cells
were stained with appropriate antibodies and analyzed by flow cytometry.
Determination of K5.D1 vs. control T cell recovery was done as previously
described (118). Briefly, the number of CD45.2+ and CD45.1+ congenic cells recovered
from recipients was determined by data analysis using FlowJo® software (TreeStar,
version 9.6.7). The ratio of CD45.2 vs. CD45.1 cells was obtained for each organ from
each recipient, and normalized by dividing this post-transfer ratio by the input ratio to
determine the change since adoptive transfer. Furthermore, the change since adoptive
transfer for K5.D1 vs. control data was normalized to control vs. control data by dividing
the former by the latter, to account for potential incorporation discrepancies between
congenic backgrounds (140).
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Adoptive transfer of sorted T cells into RAG2-/- recipients
Bulk CD4+ T cells were sorted from isolated splenocytes as described above.
Cells were pelleted by centrifugation at 1500rpm for 3 minutes, supernatant removed
and resuspended less than 200ul of PBS. Cells were counted using trypan blue viability
stain (Life Technologies) and a Countess® automated cell counter (Life Technologies).
Control or K5.D1 T cells were injected into recipient mice by retro orbital sinus injection
of anesthetized 13-15wk old C57Bl6/J RAG2-/- mice. Animals were weighed every two
days for a total of 21 days, and sacrificed for necropsy. Body mass index was
calculated as the starting weight of an animal divided by the weight on day X.

CFSE Labeling
Carboxyfluorescein succinimidyl ester (CFSE) labeling was used to monitor
proliferation in vitro and in vivo. Sorted T cells were incubated in pre-warmed 5mM
CFSE (CellTrace CFSE Cell Proliferation Kit, Life Technologies) for 10min in PBS at
37°C in the dark. Cells were washed twice with 5x volume of complete media
(supplemented with 10% FCS) to neutralize CFSE and allowed to rest 10min before
stimulating in vitro.

Cell Culture and in vitro Functional Assays
For in vitro activation and proliferation studies, FACS sorted Lin-CD8-CD44splenic T cells were stained with CFSE and seeded into 96 well plates at a
concentration of 1x105 cells per well in RPMI 1640 supplemented with non-essential
amino acids, 2mM Glutamax, 1mM sodium pyruvate, 55mM β-mercaptoethanol, 10%
FCS and antibiotics. Sorted T cells were plated along with 5x105 APCs (CD3- irradiated
splenocytes subjected to 3000 rad), and cultured in varying amounts of anti-CD3
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(1ug/ml, 500ng/ml, 100ng/ml or no anti-CD3 antibody; clone 145-2C11) and 1 ug/ml
anti-CD28 (clone 37.51) from eBioscience for 68 hours. Cells were then restimulated
with Cell Stimulation Cocktail (eBioscience) for one hour. Protein transport was blocked
(Transport Inhibitor Cocktail, eBioscience) for three additional hours and cells were
stained for cell surface markers and the intracellular cytokines IL-2, IL-4 and IFNγ.
For in vitro IL-7 experiments, FACS sorted CD8-CD44-GFP- splenic T cells were
seeded into 96 well plates at a concentration of 1x105 cells per well with varying
amounts of IL-7 (10ng/ml, 5ng/ml, 2.5ng/ml, 1.25ng/ml or no IL-7) and analyzed at 4, 8,
24, and 48 after plating. Samples were stained with propidium iodide and recorded on a
BD Fortessa® and analyzed in FlowJo® (TreeStar, version 9.6.7).
Haematoxylin and Eosin Staining
Fresh frozen sections were thawed to room temperature for thirty minutes, and
fixed using 10% neutral buffered formaldyhyde. Slides were treated with haematoxylin
(Sigma) for 10 minutes and rinsed briefly in tap water. Slides were then treated with 1%
eosin (Sigma) for 3-10 minutes and rinsed briefly in tap water. Slides were dehydrated
by increasing ethanol concentrations from 70% to 100% and washed in xylene twice for
a total of 10 minutes. Finally slides were coverslipped with cytoseal (Thermo Scientific).

Immunohistochemistry
Serial sections (5-

-embedded frozen tissue were air dried and

fixed in cold acetone or 4% paraformaldehyde at room temperature. After washing with
PBS, sections were incubated with optimal dilutions of anti-mouse Keratin 5 (Covance
Research), anti-mouse CD205 (Ly75, Abcam), anti-rat CD8-efluor 660 (eBioscience),
anti-rat ERTR7-Alexa 488 (Nova Biologicals), or anti-rat CD31-biotin (eBioscience) in
PBST/5% donkey serum at 4 °C overnight. Slides were washed in PBST and treated
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with appropriate secondary antibodies for 30min, or treated with the TSA amplification
system (Life Technologies), then washed and stained with 1:1500 dilution of DAPI for
5min. Slides were washed after DAPI staining and treated with Prolong Gold Antifade
Mountant (Life Technologies) and coverslipped for microscopy.
Additional IHC stains were performed similarly, and include: Keratin 8 (Troma 1
hybridoma, raised in house), Keratin 5 (Covance), Keratin 14 (Covance), and Ulex
Europaeus Agglutinin I (Vector Laboratories).

Autoantibody Staining (Sera Staining)
Serial sections (5-

-embedded frozen tissue from RAG2-/- mice

were air dried and fixed in cold acetone at room temperature. After washing with PBS,
sections were incubated 100ul of sera from 6-8 month old control or K5.D1 mice at 4 °C
overnight. Slides were washed in PBS and treated with anti-mouse IgG-TxRed (Vector
Laboratories) and then washed and stained with 1:1500 dilution of DAPI for 5min.
Slides were washed again after DAPI staining and treated with Prolong Gold Antifade
Mountant (Life Technologies) and coverslipped for microscopy.

Quantitative Real-Time PCR
For quantitative RT-PCR (qRT-PCR), cells were sorted directly into TRIzol (Life
Technologies) and stored at -80°C until isolated for analysis. RNA was isolated
according to the TRIzol protocol, andlinear acrylimide was utilized as a carrier where
necessary. cDNA was made from isolated RNA using the Superscript III First Strand
Synthesis kit (Life Technologies) with oligo(dT) primers, and stored at -20°C. qRT-PCR
was achieved using TaqMan primers and master mixes (Life Technologies) on a
LightCycler 480 (Roche). All reactions were run at least 3 times in duplicate for
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analysis, and the presence of single RT-PCR products were confirmed by melting
curve analysis. Reactions were normalized to the appropriate endogenous controls (αtubulin for TECs and HPRT for T cell analyses). All data was analyzed using the Livak
(-2ΔΔCT) method of qRT-PCR analysis.

Statistics
Statistical difference between two groups was achieved using a paired or
unpaired Student t Test (GraphPad Prism) as indicated. A p value of <0.05 was
considered statistically significant.
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CHAPTER THREE
PREVENTING THYMUS INVOLUTION SUSTAINS THYMOPOIESIS

3.1

Introduction
Age-associated thymus involution causes a reduction in thymopoiesis and

constricts T cell output resulting in a decreased ratio of naïve to memory T cells in the
periphery (1, 74, 109). Declining naïve T cell numbers impairs the ability to mount
robust immune responses to newly encountered antigens and ultimately increases
susceptibility to infectious disease and cancer. Therefore, it has been suggested that
preventing thymus involution would sustain a functional immune system throughout life.
Disorganization and disintegration of the TEC compartment is a major factor that
underlies the reduced ability of the involuted thymus to support thymocyte maturation
(141, 142). In earlier studies we demonstrated that targeting expression of a Cyclin D1
transgene to the TEC compartment prevents the occurrence of age-associated thymus
involution (135, 143, 144). However, these investigations utilized mice on FVB or mixed
backgrounds, which undergo thymus involution more rapidly than the C57Bl6/J mouse
strain commonly used for experimental immunological studies (145-147). To determine
if the non-involuting thymic phenotype persisted in the slower-involuting C57Bl6/J
background, the K5.CyclinD1 transgene was backcrossed onto the C57Bl6/J
background at least 10 generations. Furthermore, our previous studies did not analyze
the number or differentiation of TEC subsets. Finally, the identification of discrete
thymocyte subsets has progressed significantly since the initial characterization of this
mouse model. For these reasons, we reinvestigated thymocyte and TEC phenotypes in
K5.CyclinD1 (hereafter referred to as K5.D1) transgenic mice. The following results
confirm and expand upon our original observations and support the notion that
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sustaining the TEC compartment prevents thymus involution, which in turn, supports
continued release of naïve T cells (135, 143, 144).

3.2

Results

K5.D1 expression prevents thymus involution
The onset of thymus involution in C57Bl6/J mice is evident by two to three
months of age and progresses to severe thymus shrinkage observable by one year of
age (81, 141). Organ atrophy indicative of thymus involution is readily apparent by
gross morphology of 20 week old C57Bl6/J mice (Figure 4A, left side). In stark contrast,
the K5.D1 thymus does not undergo involution. Instead, the size of the K5.D1 thymus
continues to increase with age (Figure 4A, right side). In fact, thymus size increases to
fill the thoracic cavity, causing lung compression and death by 8-12 months of age.
H&E stained thymus sections from nontransgenic (hereafter referred to as control) and
K5.D1 littermates reveal that cortical and medullary organization is maintained in K5.D1
thymi (Figure 4B, right side). In control mice, aging is associated with progressive
disorganization of thymic structure and blurring of the demarcation between cortex and
medulla at the CMJ (Figure 4B, left magnification). This aging phenotype is already
apparent by 20 weeks in control mice (Figure 4B, left side). In contrast, thymic
organization is well maintained in the K5.D1 thymi, as evidenced by the clear
demarcation of medullary and cortical regions (Figure 4B, right magnification).
To relate the size differences of control and K5.D1 thymi with age to thymus
cellularity, we counted the total number of cells obtained from thymi of mice from 4 to
40 weeks of age. Total cellularity mainly reflects the number of thymocytes since these
cells comprise more than 95% of the thymus. Prior to the onset of thymus involution,
thymus cellularity of control mice 4-8 weeks of age averaged 1.4 x108 cells per thymus.
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Figure 4. Expression of the K5.D1 transgene in TECs prevents age-related
thymus involution and maintains thymus organization.
(A) Control and K5.D1 transgenic thymi at 6 and 20 weeks of age. (B) Representative
H&E images of 6 and 20 week control and K5.D1 littermate thymus sections show
darker cortical and lighter medullary regions. Magnification inserts depict the
delineation between cortex and medulla. (C) Thymus cellularity up to 40 weeks of age
in control and K5.D1 mice (Data is presented as mean ±SEM, where each bar
represents n≥3). (D) Quantitative RT-PCR analysis of Cyclin D1 expression in TECs
and thymocytes from control and K5.D1 mice (data is representative of three
independent experiments).
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By 12-16, 20-24 and 35-40 weeks of age control thymus cellularity declined to 66%,
36% and 30%, respectively, of the pre-involution cell number (Figure 4C, black bars).
These observations are in agreement with previous reports of thymus cellularity from
C57Bl6/J mice (147, 148). However, thymus involution does not occur in K5.D1 mice.
In fact, K5.D1 thymus cellularity increases with age (Figure 4C white bars). Thymus
cellularity in K5.D1 animals increases to 42 times the number of cells present in control
thymi at 35-40 weeks of age. Histopathological analysis of the K5.D1 thymus confirmed
that the increased K5.D1 thymus size is not due to lymphoma or thymoma (data not
shown). Furthermore, quantitative RT-PCR analysis of thymocytes and TECs from
K5.D1 mice showed that transgene expression is restricted to the TEC subset and is
not expressed in thymocytes (Figure 4D, (144)). These latter results suggest that TECspecific expression of the K5.D1 transgene may drive thymus cellularity by maintaining
and expanding the TEC microenvironment that supports thymopoiesis.

The K5.D1 transgene maintains the TEC microenvironment
A strong keratin 5 promoter drives expression of the Cyclin D1 transgene
exclusively in thymic epithelium. Thus, it is likely that the observed thymus hyperplasia
is secondary to expansion of the supporting TEC microenvironment. If so, we would
expect to observe an increasing number of TECs to support the number of thymocytes
present in the K5.D1 thymi with age. TEC cellularity was quantified in control and
K5.D1 thymi. The number of TECs in control thymi declines between 4-8 and 20-24
weeks of age, in agreement with previous reports (Figure 5A, (57)). In contrast,
increased TEC cellularity was evident in K5.D1 mice as young as 4 weeks of age and
increased 10-fold by 20-24 weeks of age. The transcription factor FOXN1 plays a key
role in regulating TEC differentiation and proliferation. Foxn1 expression has been
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Figure 5. Expression of the K5.D1 transgene expands the TEC compartment with
age.
(A) Total TEC cell number in control and K5.D1 mice at 4-8 and 20-24 weeks of age
(Data is presented as mean ±SEM, where each bar represents n≥6). (B) Quantitative
RT-PCR analysis of Foxn1 expression in TECs from control and K5.D1 mice at 6
weeks and 8 months of age Data is representative of 3 independent experiments. (C)
Representative IHC images of Keratin 5+ (K5) mTEC and Keratin 8+ (K8) cTEC
staining of 1 and 6 month control and K5.D1 thymic sections. (C) Representative IHC
images of Keratin 14+ (K5) mTEC and UEA1+ mTEC staining of 1 and 6 month control
and K5.D1 thymic sections.
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shown to decline during thymus involution (81, 148). Therefore, we asked if the
expression of Foxn1 is maintained with age in K5.D1 TECs. Thymi from control and
K5.D1 mice were enzymatically dissociated and TECs were isolated by FACS sorting
MHCII+CD45- cells directly into Trizol. Quantitative RT-PCR analysis of Foxn1
expression in control TECs demonstrated declining expression from 6 weeks to 8
months of age (Figure 5B). However, K5.D1 TECs from 6 week mice exhibited 2-fold
greater Foxn1 expression, which was sustained in K5.D1 mice 8 months of age. These
data imply that overexpressing Cyclin D1 in TECs directly or indirectly maintains Foxn1
expression with age, which may be responsible, at least in part, for sustained increase
in the number of TECs.
The presence of both the mTEC and cTEC compartment is vital for productive
thymopoiesis. Since expression of the K5.D1 transgene drives an increase in both the
number of TECs and expression of the FOXN1 transcription factor essential for their
maintenance, we asked whether the TEC microenvironment might be altered by K5.D1
transgene expression. Frozen sections from 6 week and 6 month old control and K5.D1
thymi were stained with antibodies recognizing the mTEC marker Keratin 5 and the
cTEC marker Keratin 8 (Figure 5C) or Keratin 14 and ulex europaeus agglutinin 1
(UEA1, Figure 5D). Immunofluorescence imaging revealed the distinct organization of
mTECs and cTECs in control thymi, which was maintained in K5.D1 thymi. These
results suggest that expansion of TEC numbers results in an expansion of both the
cTEC and mTEC subsets that support thymopoiesis.

Thymopoiesis increases with age in K5.D1 thymi
Our lab has previously shown that the K5.D1 transgene does not alter the
frequency of major thymocyte subsets in 4-12 week old mice (135). However, the
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distribution of major thymocyte subsets had not been determined in older K5.D1
animals. Therefore, we analyzed the thymocyte population in mice up to 24 weeks of
age to determine if thymopoiesis is altered by severe thymic hyperplasia. Thymocyte
subsets were defined by expression of CD4 and CD8 as Double Negative (DN, CD4CD8-), Double Positive (DP, CD4+CD8+), and Single Positive (CD4 SP, CD4+CD8-, and
CD8 SP, CD4-CD8+) subsets (Figure 3A). Control thymi typically contain ~2-3% DN
thymocytes, 85-90% DP thymocytes, 6-8% CD4 SP thymocytes, and 2-3% CD8 SP
thymocytes at 6 to 24 weeks of age (Figure 6A, left column). The frequency of the
major thymocyte subsets was comparable in control and K5.D1 thymi at 4-8 weeks of
age (Figure 6B). However, at later ages, the K5.D1 thymi contained a small, but
significant, decrease in the percentage of DP thymocytes that was countered by an
increased frequency of cells in the CD4 and CD8 SP subsets (Figure 6C and 6D). The
increased frequency of SP thymocytes in the K5.D1 thymus could be due to defects in
export of this subset or the result of maturation defects in the DP and or SP subsets.
Evidence that support or negate these alternative explanations will be discussed below.
Thymocyte cellularity in each subset was increased in the K5.D1 compared to
littermate thymi (Figure 6E-G). DN numbers in control 4-8 week thymi averaged 2.5 x
106 cells, DP cell numbers averaged 108 cells, and the CD4 and CD8 SP cellularities
averaged 7 x 106 and 2.6 x 106, respectively (Figure 6E). The number of all control
thymocyte subsets declined to ~58% at 12-16 weeks, and was further reduced at 20-24
weeks to just 32% of the cellularity at 4-8 weeks. On the other hand, K5.D1 thymocyte
cellularity was three times greater than littermate controls at 4-8 weeks, and continued
to increase with age. By 12-16 weeks of age, K5.D1 thymi contained ~8 times as many
cells in every thymocyte subset as control littermates (Figure 6F). K5.D1 thymocyte
cellularity in each subset increased to nearly 50 times that of involuted age-matched
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Figure 6. Distribution of major thymocyte subsets in control and K5.D1 thymi.
(A) Representative dot plots of major thymocyte subsets defined by CD4 and CD8
expression from control and K5.D1 thymi 6 and 24 weeks of age. (B) Percentage of
major thymocyte subsets at 4-8 weeks (C) 12-16 weeks (D) 20-24 weeks of age. (E)
Total cell number in each major thymocyte subset at 4-8 weeks (F) 12-16 weeks (G)
and 20-24 weeks of age. Data are presented as mean ±SEM and n≥5 for all data.
*P<0.05, **P<0.01, ***P< 0.0001, and ****P< 0.00001 using an unpaired two-tailed
Student T test.
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littermates by 20-24 weeks of age (Figure 6G). Taken together, these data reaffirm that
the capacity for thymopoiesis correlates with thymus size, which increases with age in
the K5.D1 thymus.
Thymopoiesis depends on continual influx of thymus seeding progenitors from
the bone marrow that can undergo T cell lineage commitment in the DN thymocyte
compartment. Since all subsequent stages of thymocyte development emanate from
DN precursors, we questioned whether the frequency or number of the earliest
thymocyte progenitors might be increased in K5.D1 mice to support increased T cell
development. Therefore, we analyzed the frequency and number of the four DN
subsets by flow cytometry. Thymocytes were gated on αβTCR- γδTCR- DN cells, and
DN1-4 subsets were defined by the expression of CD44 and CD25 (Figure 7A). The
frequency of DN1-4 thymocyte subsets did not change during the first 6 months of life
in either control or K5.D1 thymi (Figures 7B-D). However, the number of each DN
subset declined with age in control thymi, whereas the cellularity of each DN subset
increased in K5.D1 thymi with age (Figure 7E-G). K5.D1 mice 4-8 weeks of age
exhibited roughly three times the DN1-4 cellularity of control littermates, whereas the
DN subset cellularity in 12-16 week old K5.D1 thymi increased 5-fold compared to
controls. By 20-24 weeks of age, cellularity in the K5.D1 DN subsets expanded to
nearly 50 times that of involuted control littermates. Therefore, expanding the TEC
microenvironment using the K5.D1 transgene supports a larger pool of immature
thymocytes.
The DN1 thymocyte subset is comprised of a heterogeneous mixture of
progenitor cell types capable of differentiation to the B, T, NK and DC lineages. Early
thymocyte progenitors (ETPs) are most effective at developing towards the T cell
lineage but reflect only a small fraction of the DN1 subset of cells and are identified by
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Figure 7. Distribution of DN thymocyte subsets in control and K5.D1 thymi.
(A) Gating scheme and representative dot plots of DN thymocyte subsets. (B)
Percentage of DN thymocyte subsets at 4-8 weeks (C) 12-16 weeks (D) 20-24 weeks
of age. (E) Total cell number of DN thymocyte subsets at 4-8 weeks (F) 12-16 weeks
(G) and 20-24 weeks of age. Data are presented as mean ±SEM and n≥4 for all data.
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the dual expression of CD44 and c-kit. Previous work established that the frequency
and number of ETPs decline with age in wild type thymi (149). Because the K5.D1
thymus supports increased numbers of developing thymocytes, we questioned whether
the size of the ETP population might be increased. To identify ETPs, we gated on
αβTCR- γδTCR- DN cells that express both CD44 and c-kit, and did not express the
DN2 marker CD25 (Figure 8A). In agreement with published reports, both the
frequency and number of ETPs declined in control mice with age (Figures 8B-C, (149)).
Interestingly, the frequency of ETPs in K5.D1 thymi was not significantly different from
controls (Figure 8B). However, the number of ETPs in the K5.D1 thymus was five-fold
greater than observed in control mice, and maintained with age (Figure 8C). Therefore,
these data support the hypothesis that the increased K5.D1 thymopoiesis stems from
an expansion of TEC niches that support ETP survival and differentiation.

The increased frequency of mature SP thymocytes in K5.D1 thymi is due to
accumulation of late maturation stage cells.
We observed significant increases in CD4 SP and CD8 SP subset frequencies in
K5.D1 mice with age (see Figure 6B-D). SP thymocytes are a heterogeneous
population consisting of cells at progressive maturation stages that have been defined
phenotypically by expression of various surface markers (150). For example, CD69
expression is driven by TCR engagement during positive selection and persists on
early, but not late stage SP thymocytes, whereas Qa-2 expression is acquired on late
stage SP thymocytes prior to thymic exit. To determine if the increased percentage of
SP thymocytes was due to relatively immature or mature SP subsets, we analyzed the
frequency of early (CD69+Qa-2-) and late (CD69-Qa-2+) stage CD4 and CD8 SP
thymocytes in control and K5.D11 thymi (Figure 9A). The frequency of late stage SP
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Figure 8. The number of ETPs declines with age in control but not in K5.D1
thymi.
(A) Gating scheme to identify ETPs within the thymocyte population. Total thymocytes
were gated as γδTCR-αβTCR-CD44+CD117+ subsets, and ETPs were discriminated by
CD25- expression. (B) Frequency of ETPs in control and K5.D1 with age. (C) Number
of ETPs in control and K5.D1 with age. Data are presented as mean ±SEM and n≥4 for
all data. *P<0.05 and ***P< 0.0001 using an unpaired two-tailed Student T test.
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Figure 9. SP thymocytes accumulate in the K5.D1 thymus by 12-16 weeks of age.
(A) Representative dot plots of early SP thymocytes (CD69+Qa-2-) versus late stage
(CD69-Qa-2+) SP thymocyte frequency in control and K5.D1 thymi. (B) Scatter graph of
the frequency of late stage SP thymocytes with age (n≥3, data from 2+ independent
experiments per age group). (C) Frequency of BrdU+ thymocytes after 16hr labeling 812 week control and K5.D1 thymi (n≥3). (D) Frequency of GFP- T cells reentering the
CD4 and CD8 SP populations (n≥3). All Bar graphs are represented as mean ±SEM.
*P<0.05, **P<0.01, ***P< 0.0001 using an unpaired two-tailed Student T test.
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thymocytes does not change appreciably in control mice with age (Figure 9B).
However, we observed significant increases of late stage SP thymocytes in K5.D1
thymi with age (Figure 9B).

Potential mechanisms accounting for the increase in late stage SP thymocytes
We considered several mechanisms that could explain the increase in late stage
SP thymocytes in aged K5.D1 mice. For instance, the increased percentage of late
stage SP thymocytes may be due to an increased thymocyte proliferation (Figure 9C).
However, we did not observe an increase in the percentage of K5.D1 thymocytes that
incorporated BrdU after an overnight pulse. We also considered the possibility that the
increased frequency of mature SPs may be due to accumulation of mature peripheral T
cells that circulated back into the thymus. To test this possibility, we analyzed the
frequency of GFP- T cells present in the SP thymocytes within RAG2p-GFP control or
RAG2p-GFP;K5.D1 transgenic thymi (Figure 9D). While the frequency of recirculating
GFP negative cells in the SP thymocyte subsets increased in both control and K5.D1
thymi with age, there was no appreciable difference between these frequencies in aged
control and K5.D1. Additionally, the increased frequency of recirculating cells does not
account for the increasing size of the SP thymocyte subsets in K5.D1 mice with age.
It is also possible that aberrant selection in the K5.D1 thymic microenvironment
could play a role in the altered distribution of thymocyte subsets. We previously
examined potential alterations of positive and negative selection in K5.D1 mice using
the H-Y TCR transgenic model (135). In this experimental system, all developing
thymocytes express a TCR specific for the Y chromosome-encoded male antigen
presented by the H2-Db MHC molecule. Negative selection deletes these specific
thymocytes in male mice, whereas the same TCR transgenic thymocytes undergo
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positive selection to become CD8 T cells in female thymi expressing the H2-Db
haplotype. Despite the fact that positive and negative selection appeared normal in H-Y
TCR; K5.D1 double transgenic mice, it remained possible that the K5.D1
microenvironment would affect negative or positive selection in non-transgenic
thymocytes. However, it is difficult to directly interrogate selection induced by selfpeptide/MHC complexes in polyclonal populations. To approach the issue of positive
selection, we examined Nur77 expression on DP thymocytes. Nur77 is an immediate
early gene upregulated by TCR stimulation. The Nur77-GFP transgene faithfully reports
TCR signal strength during thymopoiesis and peripheral T cell stimulation (151). To
analyze Nur77 expression on DP thymocytes, we crossed Nur77-GFP transgenic mice
with K5.D1 mice, and the double transgenic mice were analyzed for Nur77 expression
by flow cytometry to assess TCR activation of DP thymocytes during positive selection
(Figure 10A). There was no observed difference in frequency or the mean fluorescence
intensity (MFI) of Nur77 expression on DP cells from control or K5.D1 thymi (Figure
10B and 10C). These results suggest that there is no overt defect in positive selection
in K5.D1 mice. Additionally, we analyzed CD5 expression as an independent indicator
of the strength of TCR engagement (personal communication from KA Hogquist) and
confirmed no difference of CD5 expression between control and K5.D1 DP thymocytes
(Figure 10D).
Deficient negative selection is another potential explanation for the relative
increase in mature SP thymocytes in K5.D1 thymi. To address this possibility, we
analyzed CD5 expression on early stage CD4 SP thymocytes identified by the
CD69+Qa-2- phenotype. This subset of cells undergoes negative selection by TCR
engagement with TRAs presented by mTECs or DCs, and this results in CD5
expression. Low CD5 expression on K5.D1 early CD4 SP thymocytes would suggest
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Figure 10. Positive and negative selection K5.D1 thymi are comparable to
controls.
(A) Representative histogram of Nur77 expression in control and K5.D1 DP
thymocytes. (B) Frequency of Nur77-GFP+ expressing cells in control and K5.D1 DP
thymocytes. Data are presented as mean ±SEM and n≥3 for all data. (C) Mean
fluorescence intensity (MFI) of Nur77-GFP expression in GFP+ DP thymocytes from
control and K5.D1 thymi. (D) Representative histograms of CD5 expression on control
and K5.D1 DP thymocytes at 6, 12, and 24 weeks of age. (E) CD5 expression on CD4
late stage (CD69-Qa-2+) thymocytes from control and K5.D1 thymi at 6, 12, and 24
weeks of age.
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lower TCR signaling strength and potentially less negative selection in the K5.D1
thymus, whereas increased CD5 expression would suggest higher levels of TCR
activation and increased negative selection. However, CD5 expression on K5.D1 early
stage SP thymocytes was indistinguishable from expression on thymocytes from
control mice (Figure 10D-E). These data suggest that the increased frequency of
mature SPs is not a consequence of defective TCR signaling leading to inefficient
negative selection. However, other factors such as deficient TRA expression could
result in inefficient negative selection. If negative selection were impaired, we would
expect an increase in autoimmune symptoms. Therefore, we used several approaches
to determine if K5.D1 mice are prone to autoimmunity. First, we treated tissue sections
from RAG2-/- skin and kidney with serum from 6-8 month control and K5.D1 mice to
assay for the presence of autoantibodies. As a positive control we used CCR7 -/- mice,
in which negative selection is impaired resulting in the escape of autoreactive T cells
and autoantibody production. CCR7-/- serum produced strong immunofluorescence
staining on RAG2-/- tissues (Figure 11A, top row). In contrast, serum from K5.D1 mice
showed no evidence of increased autoantibodies when compared to serum from
control mice (Figure 11A). Histopathological analyses of tissues from 6-8 month old
control and K5.D1 mice showed no lymphocyte infiltration in liver, lung, pancreas or
extraorbital gland, further suggesting that the K5.D1 microenvironment does not
promote autoimmunity (See Appendix 1). However, it remained possible that defective
negative selection would generate autoreactive K5.D1 T cells but this potential could be
suppressed by repressive influences of Tregs in the K5.D1 environment. To test this
premise, we FACS sorted splenic CD4 T cells from control or K5.D1 mice and
adoptively transferred them into RAG2-/- recipients that cannot produce T and B cells
(Figure 11B). Recipients were weighed every other day for three weeks, and then
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Figure 11. K5.D1 T cells do not exhibit autoreactivity when adoptively transferred
into RAG2 deficient hosts. (A) IHC images from RAG2-/- tissues stained with sera
from K5.D1 or control mice. (B) RAG2-/- recipients were injected with sterile PBS or
FACS-sorted CD4 T cells (>99% purity) from control or K5.D1 mice and weighed every
two days to determine changes in body mass index.
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necropsied to determine if the transferred cells generated an autoimmune response in
the absence of host regulatory T cells. During this timeframe, recipients given K5.D1 T
cells remained healthy and retained body weight indices that were comparable to
recipients injected with control CD4 T cells or sterile PBS. Additionally, a blind
pathological reading of slides from multiple organs including lung, pancreas, intestines,
extraorbital lacrimal and salivary glands did not reveal any lymphocyte infiltrates or
other signs of autoreactivity in recipients (Appendix 2). Thus, we conclude that there is
no evidence for aberrant central tolerance induction in the K5.D1 thymus and therefore,
the accumulation of mature SP thymocytes is unlikely to be due to a defect in negative
selection.
Finally, we asked whether the increased frequency of mature SP thymocytes
could be due to an accumulation of cells from defective thymic export. Thymic
emigration from vessels at the CMJ relies on the expression of S1P1R on thymocytes
to follow the S1P cytokine gradient produced by the pericytes lining the vasculature to
exit the thymus (42). FACS analysis of S1P1R was not feasible due to poor antibody
staining index, which was corroborated by the manufacturer. Instead, we determined
whether SP thymocytes were being held up in the perivascular spaces around the
vasculature by IHC, which is indicative of defective thymus emigration (42). Paraffin
sections of K5.D1 or control littermate thymi at 1, 3 and 6 months of age were stained
for CD8, CD31 and ERTR7, which identify CD8 thymocytes, endothelium and epithelial
basement membranes, respectively. Surprisingly, there was no accumulation of
thymocytes within the perivascular spaces of K5.D1 thymi, regardless of age (Figure
12A). This result suggests that increasing SP thymocyte frequency is not due to
emigrating thymocytes held up in perivascular spaces. It is possible that defects prior to
entry into the vascular space could affect export. In order to test for this scenario, we
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Figure 12. Late stage SP thymocytes do not exhibit defective thymus emigration
but experience longer thymus residency than controls. (A) Representative IHC
images depicting thymocytes localization around thymus vasculature. (B)
Representative histograms show GFP expression in early and late stage CD4 SP
thymocytes from RAG2p-GFP and K5.D1;RAG2p-GFP mice (data representative of
three independent experiments).
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analyzed the level of GFP expression in SP thymocytes from K5.D1;RAG2p-GFP thymi
and RAG2p-GFP controls. Since the RAG2p-GFP transgene is only expressed during
TCR rearrangement, loss of GFP protein in later thymocyte stages can be utilized as a
molecular clock to determine the relative rate of thymocyte maturation. To show proof
of principle, late stage SP thymocytes exhibit lower levels of GFP than early stage SP
thymocytes in control mice (Figure 12B, left histogram). Therefore, we used this
scheme to determine if cells were retained in the late stage SP subset. Our data show
that K5.D1 early stage SP thymocytes contain similar levels of GFP as control
counterparts (Figure 12B, middle histogram). However, late stage SP thymocytes from
K5.D1 thymi did contain lower GFP signal (Figure 12B, right histogram). Furthermore,
GFP expression was not expressed as a signal peak by histogram, but as a range of
GFP intensity implying that many K5.D1 late stage SP thymocytes are retained for a
long period of time. Therefore, these results suggest that a delay does exist in the
maturation or export of the most mature thymocytes in K5.D1 thymi.

An increase in thymic K5.D1 Tregs does not equate to increased peripheral Tregs
The generation of regulatory T cells (Treg) both in the thymus and peripheral
tissues is necessary to down modulate the immune response, a process that plays an
essential role in preventing autoimmunity. Thymocytes with strong reactivity to self are
either deleted or diverted to the Treg developmental program. Because of the
expanded thymus size and increased thymopoiesis, we asked if thymic Treg generation
was altered in K5.D1 mice. The expression of both CD25 and intracellular Foxp3
identifies CD4 SP mature Treg cells in the thymus (Figure 13A). Using this identification
strategy, we have found that there is an increase in both frequency and number of
mature Treg cells in the K5.D1 thymus with age (Figure 13B). To determine if there was
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Figure 13. The frequency of Tregs is increased in K5.D1 thymi but not in the
peripheral T cell pool. (A) Representative dot plots of CD25+Foxp3+ Treg thymocytes
and splenocytes from control and K5.D1 mice. (B) Scatter graph of the % of Tregs in
thymocytes (C) Scatter graph of the % of Tregs in splenic T cells. Note that thymic Treg
frequency is significantly increased in K5.D1 mice, yet splenic Treg frequency is not
significantly altered (C). **P<0.001 for bracketed values using an unpaired Student’s T
test.
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a corresponding increase in peripheral Treg cells, we analyzed the frequency of mature
Treg cells within the splenic CD4 T cell population. The data show that the frequency of
peripheral Tregs in K5.D1 spleens remained comparable to controls, and was not
influenced by increased Treg frequency in K5.D1 thymi (Figure 13C).

3.3

Discussion
Taken together, our data indicate that robust thymopoiesis is supported and

increased by expansion of the TEC compartment in aging K5.D1 thymi. Recently, TECspecific deletion of Retinoblastoma (Rb) family genes was shown to prevent thymic
involution and cause thymus expansion similar to the phenotype in K5.D1 mice. Rb
family members regulate cell cycle progression and gene expression by binding and
inhibiting E2F transcription factors (152). Rb conditional knockout TECs had increased
E2F3 activity, which in turn increased Foxn1 expression. The similarities in the K5.D1
transgenic and Rb inactivation models strongly suggest that the CyclinD1-Rb axis is
critical for maintaining the TEC compartment and can be manipulated to prevent
thymus involution.
The increased TEC niches within the K5.D1 thymus support survival and
differentiation of a larger population of ETPs. In fact, we observed a 5-fold increase in
ETP number that was maintained with age in K5.D1 thymi. Our results suggest that the
decline of ETP numbers with age is secondary to the degeneration of the TEC
compartment. Since thymopoiesis relies on ETPs to establish and maintain the
developing thymocyte population, the ramifications of involution on the entire thymocyte
pool are evident even in early thymus involution. Furthermore, avoiding involution by
the K5.D1 transgene increases the size of the developing thymocyte population, thus
exemplifying the importance of the TEC microenvironment for thymocyte development.
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Stringent positive and negative selection occurs in the K5.D1 thymus, owing to
the maintenance of the TEC microenvironment. As evidenced by TCR engagement
studies and T cell transfers into immunocompromised mice, developing thymocytes in
the K5.D1 thymus are self-restricted and self-tolerant. Moreover, T cells derived from
the K5.D1 thymus do not impose autoreactivity on peripheral tissues. These results
show that maintaining the thymic architecture is central to the continued output of
protective T cells with age.
We observed the increasing frequency of SP thymocytes with age in K5.D1
thymi. Several explanations including increased thymocyte proliferation, delayed
thymocyte maturation or perivascular retention failed to explain our observations.
Furthermore, SP thymocytes specifically accumulated during the last stage of
thymocyte maturation, but were not crowded around the vasculature. Aberrant
expression of CD62L necessary for export was not found in the accumulating cells.
Thus, the mechanism for this retention remains unclear, but appears to relate in some
manner to organ size.
Finally, we observed that the frequency of thymic Tregs significantly increases
with age. A recent report showed that peripheral Tregs increasingly recirculate through
the thymus with age to inhibit continued Treg generation (153). Unfortunately we
cannot definitively state whether the increased frequency of thymic Tregs is due to
increased generation or recirculation. However, the frequency of thymic Tregs did not
influence the frequency of peripheral Tregs, which suggests that the thymic Treg
phenotype is organ-specific.
Taken together, the data in this chapter suggest that thymocyte development in
K5.D1 thymi results in increased production of self-tolerant T cells.
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CHAPTER FOUR
ALTERATIONS TO THE PERIPHERAL T CELL POOL ARE PRECIPITATED BY
EARLY THYMUS INVOLUTION

4.1

Introduction
The distribution of naïve and memory T cells is severely altered by the decline in

naïve T cell output from involuted thymi as well as by life-long antigenic stimulation
(Reviewed in (154)). Age-associated changes in the T cell pool are blatant by old age,
including the decline of naïve T cell numbers, naïve T cell exhaustion, and increasing
memory T cell frequency. The reduction in naïve T cells restricts TCR repertoire
diversity, which results in deficient responses to new antigens (5, 112, 134, 155, 156).
Therefore, the aging process decreases the capability of the T cell pool to protect
against infectious diseases and cancer and is associated with an increased incidence
of autoimmunity.
Thymus involution is the major factor responsible for the age-associated decline
in naïve T cells. There are a few reports that investigate T cell output during the entire
lifespan or chronicle peripheral T cell changes as a result of natural aging (4, 5, 155,
157). However, studies investigating the population dynamics of naïve and memory T
cells with age have failed to consider the ramifications of early thymus involution on this
process. Furthermore, it has been suggested that preventing thymus involution will
preclude the age-associated changes in the T cell pool, including the shift in naïve and
memory representation, defects in T cell function and reduced TCR repertoire diversity.
To address these points, we analyzed the distribution of naïve and memory T cells
during early stages of thymus involution in wildtype mice up to 24 weeks of age. We
also performed comparative analyses of these parameters in K5.D1 transgenic mice
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that do not undergo thymus involution. To distinguish RTEs from MN T cells in the
naïve T cell pool, we used RAG2-pGFP transgenic mice that did or did not express the
K5.D1 transgene. In addition to analyzing phenotypic parameters, we also determined
the functional potential of naïve T cells in nontransgenic and K5.D1 transgenic mice as
a function of age.

4.2

Results

Sustained thymopoiesis in K5.D1 mice prevents loss of naïve T cells during aging
The majority of studies determining the influence of thymus size and output on
the T cell pool utilize mice more than three months of age for a young time point and
aged mice over a year old as comparators (4, 5, 155, 157). However, early thymus
involution is apparent from the significant decrease in organ size and cellularity by 1216 weeks of age in control mice (Figure 14A). Therefore, we posed two separate
questions: First, we asked whether declining thymopoiesis during early thymus
involution (12-24 weeks of age) affected the size of the peripheral T cell pool.
Additionally, we questioned whether preventing early involution would affect the
composition of the T cell pool. Splenic cellularity remained consistently at ~50 x 10 6 in
control mice up to 24 weeks of age (Figure 14B). However, K5.D1 splenic cell number
significantly increased (p=0.0008) by 12-16 weeks of age, and was sustained at 20-24
weeks of age. Intriguingly, increased K5.D1 splenic cellularity did not mirror the
extreme increase of thymic cell numbers observed with age. This result is consistent
with previous studies showing that a peripheral homeostatic mechanism maintains a
relatively constant number of total peripheral T cells (158). The modest increase in
splenic cellularity in K5.D1 mice was due solely to a three-fold increase in T cell
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Figure 14. Preventing thymus involution in K5.D1 mice increases the size of the
peripheral T cell pool.
(A) Thymus cellularity in control and K5.D1 mice with age. (B) Splenic cellularity is
increased in K5.D1 mice. (C) Increased splenic cellularity is due solely to increased T
cell numbers in K5.D1 mice. (D) Increased splenic numbers are not due to increased B
cell numbers. (E) T cell numbers decline in control mice in the axial and (F) inguinal
lymph nodes with age, whereas cell numbers remain inflated in K5.D1 mice with age.
n≥3 for all data, *P<0.05 using a two-tailed Student T test.
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numbers (Figure 14C). The number of splenic B cells was comparable in control and
K5.D1 mice (Figure 14D).
The secondary lymphoid organs (SLO) include lymph nodes throughout the
body as well as the spleen. We analyzed the number and frequency of T cells in the
control and K5.D1 axial and inguinal lymph nodes to determine if the splenic
phenotypes observed in control and K5.D1 spleens were mirrored in other SLO. T cell
numbers decreased with age in both lymph node sites in control animals (Figure 14EF) whereas the increased numbers of T cells in K5.D1 mice were maintained during
aging. These results demonstrate that even in young mice, the initial stages of thymus
involution drive the reduction of T cell numbers in the spleen and lymph nodes. In
contrast, peripheral T cell numbers are elevated in K5.D1 mice. However, the
increased cellularity is not altered by aging, and is instead maintained at a relatively
constant cellularity up to 24 weeks of age. This result suggests that the T cell numbers
are at maximal capacity in K5.D1 SLO.

Early thymus involution is associated with decreased frequency and number of naïve
CD4 T cells and a corresponding increase in memory T cells.
The helper CD4 T cell population is comprised of both naïve and memory
subsets that decrease and increase, respectively, with age. Severe thymus involution in
mice one year or older is associated with a skewed frequency of naïve and memory T
cells. We asked whether early stages of involution also compromise the composition of
the T cell pool in young individuals. To determine the impact of early thymus involution
on the distribution of naïve and memory CD4 T cells, we used flow cytometry to identify
memory T cells by CD44+CD62L- expression and naïve T cells by CD44-CD62L+
expression (Figure 15A). There was a striking decline in the frequency of naïve T cells
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Figure 15. Thymus involution alters the distribution of naïve and memory T cells
in splenic CD4 T cells.
(A) Representative FACS plots of naïve (CD44-CD62L+) and memory (CD44+CD62L-)
CD4 T cells from 6wk and 24wk control and K5.D1 mice. (B) Frequency of naïve CD4+
splenic T cells in control and K5.D1 mice with age (C) memory T cell frequency
increases. (D) CD4+ naïve T cell number decline significantly in control mice as a result
of thymus involution, whereas K5.D1 naïve T cell number increases. (E) Memory T cell
numbers increase with age in both control and K5.D1 mice. n≥5 for all data, *P<0.05,
**P<0.01, ***P< 0.0001 ****P,0.00001 using a two-tailed Student T test.
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in control mice with age (Figure 15B), which was accompanied by a corresponding
increase in the frequency of memory T cells (Figures 15C). In contrast, there was no
change in the frequency of naïve and memory T cells in the K5.D1 T cell
pool. Cellularity data revealed a significant decline in the number of naïve T cells
(Figure 15D) in control mice, coupled with a significant increase in the number of
memory T cells. On the other hand, K5.D1 naïve T cell numbers increase three-fold by
12-16 weeks of age, plateauing by 20-24 weeks of age (Figure 15D). However, the
increase in naïve T cell numbers does not affect the generation of memory T cells in
K5.D1 mice (Figure 15E). The independent changes in naïve and memory T cell
numbers strongly supports the notion that naïve and memory T cells occupy distinct
niches. This concept is consistent with the fact that homeostasis of naïve and memory
populations are regulated by different cytokines (109, 159). Taken together these
results demonstrate that early thymus involution in control mice significantly reduces
the cellularity of the naïve T cell compartment and expands the memory T cell
compartment. In contrast, the absence of thymus involution in K5.D1 mice prevents the
loss of naïve T cells and maintains a relatively constant naïve to memory T cell ratio.

Early thymus involution is associated with decreased frequency of naïve CD8 T cells
and a corresponding increase in memory T cells.
The frequency of naïve and memory T cells in the CD8 population is driven toward
memory T cell dominancy by the reduction of naïve T cells due to reduced thymic
output and to expansion of memory T cells. We questioned whether early stages of
involution compromise the composition of the T cell pool in young mice. To test this, we
turned again to flow cytometry to identify naïve and memory CD8 T cell subsets (Figure
16A). Similar to the CD4 population, naïve T cells in the CD8 population are identified
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Figure 16. Thymus involution alters the distribution of naïve and memory T cells
in splenic CD8 T cells.
(A) Representative FACS plots of naïve (CD44-CD62L+), effector memory
(CD44+CD62L-) and central memory (CD44+CD62L+) CD8 T cells from 6wk and 24wk
control and K5.D1 mice. (B) The frequency of naïve CD8 splenic T cells decline with
age in control mice while (C) effector memory and (D) central memory T cell frequency
increases. (E) CD8 naïve T cell numbers remain constant in control mice up to 24
weeks of age, whereas K5.D1 naïve T cell number increase. (F) Effector memory T cell
numbers in both control and K5.D1 mice. (G) Central memory T cell numbers in control
mice and K5.D1 mice with age. n≥5 for all data, *P<0.05, **P<0.01, ***P< 0.0001
****P,0.00001 using a two-tailed Student T test.
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by CD44-CD62L+ expression. However, the CD8 memory subset is comprised of two
easily distinguishable types of T cells that exert separate responses upon reinfection
(160). Effector memory (EM) T cells are typically found in the spleen and peripheral
tissues after an immune response and are identified by CD44+CD62L- expression.
Central memory (CM) T cells, on the other hand, usually home to the lymph nodes and
identified by CD44+CD62L+ expression (111).
We analyzed the frequency and number of naïve, EM and CM T cells in the CD8
T cell population. The frequency of CD8 naïve T cells in control mice declined
significantly with age (Figure 16B), which was accompanied by a corresponding
increase in the frequency of both EM and CM T cells (Figures 16C and 16D). In
contrast, there was no loss of naïve or increase in memory T cell frequency in the
K5.D1 CD8 T cell population (Figure 16B and 16C). Cellularity data revealed sustained
numbers of CD8 naïve T cells (Figure 16E) in control mice. This result was not
unexpected, as multiple groups have demonstrated that CD8 naïve T cell numbers do
not decline until at least 8 months of age in mice (156, 161, 162). Furthermore, we
observed a significant increase in the number of both EM and CM T cells with age in
control mice (Figure 16F and 16G). In contrast, K5.D1 naïve T cell numbers increased
at least three-fold by 12-16 weeks of age and plateaued thereafter (Figure 16E).
However, the increase in naïve T cell numbers does not impede the expansion of EM
or CM T cells in K5.D1 mice (Figure 16F and 16G). We did note increased numbers of
K5.D1 CM T cells at 4-8 and 12-16 weeks of age in the CD8 population compared to
controls. However, this change was corrected at 20-24 weeks, such that K5.D1 and
control CM numbers were not significantly different at this age. Thus, the independent
changes in naïve and memory CD8 T cell numbers further support speculation that
naïve and memory T cells reside in distinct niches. Together with our CD4 T cell data,
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these results demonstrate that early thymus involution in control mice significantly
reduces the frequency of the naïve T cell compartment and expands the memory T cell
compartment. In contrast, the absence of thymus involution in K5.D1 mice maintains
increased naïve T cell numbers that do not impact the expansion of CD8 memory T cell
subsets.
Requirements for T cell entry to the spleen are not as stringent as entry
requirements to the lymph nodes, which rely on CD62L and CCR7 expression for
migration into lymph node bodies (163, 164). To confirm that the CD4 and CD8
changes were not isolated to the splenic T cell population, we assayed the frequency of
naïve and memory T cells in the lymph nodes. Control mice displayed a loss of naïve T
cell frequency in the axial lymph nodes along with memory generation that was similar
to changes observed in the spleen (Figure 17). In contrast, K5.D1 lymph nodes
exhibited no change in the frequency of naïve or memory T cells with age. Analysis of
naïve and memory populations in inguinal lymph nodes yielded similar results (data not
shown). Therefore, we conclude that early thymus involution drives significant decline
of naïve T cell frequency and number coupled with increasing memory T cell frequency
and number in SLOs. These novel findings demonstrate that early thymus involution is
the precipitating factor behind age-associated changes in the peripheral T cell pool.

K5.D1 thymi sustain RTE output preventing a decline in MN T cells with age
The naïve T cell pool consists of phenotypically and functionally heterogeneous
cells due to the presence of both RTEs and mature naïve (MN) T cells. RTEs must
migrate into SLOs to undergo phenotypic and functional maturation to antigen
responsive MN T cells. Continual RTE output from the young thymus not only
maintains the size of the naive T cell pool, but also maintains TCR repertoire diversity
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Figure 17. Thymus involution alters the distribution of naïve and memory T cells
in lymph nodes.
(A) Representative FACS plots of naïve (CD44-CD62L+) and memory (CD44+CD62L-)
CD4 T cells from 6wk and 24wk control and K5.D1 mice. (B) Naïve and (C) memory T
cell frequency from the CD4 T cell population. (D) Naïve and (E) memory T cell
frequency from the CD8 T cell population. n≥3, *P<0.05 using a two-tailed Student T
test.
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needed for robust primary T cell responses. However, the number of RTEs produced
by the thymus declines during thymus involution (72) To determine if preventing thymus
involution sustains the number of RTE and MN T cells during aging, we compared the
composition of the naïve T cell pool in control and K5.D1 mice. To identify the RTE and
MN T cell subsets, we bred the RAG2p-GFP transgene onto the K5.D1 background to
identify RTEs in K5.D1 transgenic and non-transgenic littermates by GFP labeling
(Figure 18A). The RAG2p-GFP transgene identifies RTEs released from the thymus
within one week of analysis (GFPhi), RTEs that have resided for one to three weeks in
the periphery (GFPlo) and mature naïve (MN) T cells (GFPneg) that have resided in the
periphery for three or more weeks (Figure 18B). Electronic gates for these subsets
were established in CD4 and CD8 splenic naïve T cell subsets. The GFP hi gate was set
using SP thymocytes, since all cells in this subset were recently labeled with GFP
during the DP stage and indicate the brightest GFP+ cells (Figure 18B).
Analysis of GFP expression in naïve CD4 T cells from control mice revealed that
the frequency of GFPhi and GFPlo RTEs declines during early involution (Figure 19AC), whereas MN T cell frequency increases with age (Figure 19D). Furthermore, the
absolute number of RTEs also declines, which in turn results in a significant decrease
of MN T cells by 20-24 weeks of age (Figure 19E-G). Since MN T cells are required to
mount T cell responses to new antigens, these data suggest that even early stages of
thymus involution may negatively affect the quality of primary immune responses.
However, in the absence of thymus involution in K5.D1 thymi, RTE output does not
decline (Figure 19A-C). Instead, the number of RTEs and MN T cells increases
between 4-8 and 12-16 weeks of age and is sustained thereafter (Figure 19E-G).
Nevertheless, we noted that the frequency of MN T cells is lower than that of RTEs,
whereas the reverse is true in controls. This suggests that T cells are lost during
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Figure 18. Identification of RTEs and MN T cells in RAG2p-GFP transgenic mice.
(A) Breeding scheme to generate Control and K5.D1 mice. (B) Gating scheme to
define GFPhi GFPlo and GFPneg T cell subsets in the spleen is determined by GFP
signal intensity in SP thymocytes.
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Figure 19. Changes in the frequency and number of CD4 RTEs and MN T cells
with age in control and K5.D1 thymi.
(A) Representative FACS plots of GFPhigh, GFPlow, and GFPneg mature naïve (MN) CD4
T cells depict the loss of T cell output with age in control mice. (B) Frequency of GFPhi
RTEs, (C) GFPlo RTEs and (D) MN CD4 T cells in control and K5.D1 mice with age. (E)
Number of GFPhi RTEs, (F) GFPlo RTEs and (G) MN CD4 T cells in control and K5.D1
mice with age. n≥5 for all data, *P<0.05, **P<0.01 using a two-tailed Student T test.

95

maturation of RTEs to the MN T cells stage. This is most likely due to homeostatic
constraints, such as the limited availability of IL-7 and MHCII, which cannot sustain
large numbers of naïve T cells.
We also analyzed the frequency and number of RTEs and MN T cells in the CD8
naïve T cell compartment (Figure 20). In general, the results were similar to those
found in the naïve CD4 subset. Both the frequency and number of GFP hi and GFPlo
naïve CD8 T cells declined in controls, but not in K5.D1 thymi. However, the number of
MN CD8 T cells did not decline with age in control mice. Others have shown that CD8
naïve T cell numbers do not significantly decline until at least 8 months of age (156,
161, 162). Taken together, these results further support our finding that early thymus
involution reduces RTE contribution to the peripheral T cell pool, and promotes the
age-associated shift toward memory T cell dominancy.
A previous report demonstrated that RTE output is a function of thymus size and
is relatively age-independent (72). In order to determine if RTE output was affected by
increased thymopoiesis in K5.D1 mice, we performed a similar analysis by determining
the ratio of CD4 RTEs to 100 DP thymocytes (Figure 21A). We observed similar results
when comparing CD8 RTEs to 100 DP thymocytes (Figure 21B). The data show that
similar to the controls, RTE output/100 DP thymocytes is age independent,
emphasizing the importance of thymopoiesis for sustaining the RTE content of the
peripheral T cell pool.
Overall, our results demonstrate that in control mice, the contribution of RTEs to
the naïve T cell compartment is diminished by 6 months of age. At this age, thymus
involution and disorganization of thymic architecture are apparent. However, these
changes are not as severe as the thymic degeneration that occurs in mice more than
one year of age. Nonetheless, we find that even the apparently minor alterations that
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Figure 20. Changes in the frequency and number of CD8 RTEs and MN T cells
with age in control and K5.D1 thymi.
(A) Representative FACS plots of GFPhigh, GFPlow, and GFPneg mature naïve (MN) CD8
T cells depict the loss of T cell output with age in control mice. (B) Frequency of GFPhi
RTEs, (C) GFPlo RTEs and (D) MN CD8 T cells in control and K5.D1 mice with age. (E)
Number of GFPhi RTEs, (F) GFPlo RTEs and (G) MN CD8 T cells in control and K5.D1
mice with age. n≥5 for all data, *P<0.05, **P<0.01 using a two-tailed Student T test.
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99

Figure 21. RTE output in K5.D1 and control mice is independent of age.
(A) Ratio of CD4 GFP+ RTEs compared to 100 DP thymocytes from control and K5.D1
mice. (B) Ratio of CD8 GFP+ RTEs compared to 100 DP thymocytes from control and
K5.D1 mice. n≥4 for all data.
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occur during early stages of thymus involution influence the composition of the
peripheral T cell pool. Moreover, the age-related decline in RTE output and naïve T cell
numbers can be overcome by maintaining the TEC compartment, which prevents
thymus involution.

Phenotypic Maturation of RTEs in Control and K5.D1 mice
As RTEs transition to the MN stage, there are consistent changes in the
expression of various cell surface proteins that regulate interactions with the
surrounding environment to provide optimal survival and activation signals (115, 117).
Entry into secondary lymphoid organs is crucial for the execution of RTE maturation
(120). Due to the increased number of RTEs present in K5.D1 peripheral T cell pool,
we questioned whether RTE maturation might be altered in K5.D1 mice. If RTE
maturation were delayed in K5.D1 mice, we would expect to see significant expression
differences of RTE maturation markers during the transition from GFPhi RTE to MN T
cells. Therefore, we analyzed CD4 and CD8 naïve T cells to determine if phenotypic
maturation was comparable in GFPhi, GFPlo or GFPneg cells from control and K5.D1
mice at 12 weeks of age (Figure 22). The expression of L-7Rα, Qa-2 and CD45RB
increases as control RTEs mature from GFPhi to GFPneg MN T cells (72). We found that
a similar pattern when analyzing expression of the same surface markers on K5.D1
RTEs and MN T cells. These data suggest that K5.D1 RTEs undergo typical
phenotypic maturation. It has been reported that RTE maturation is delayed in old mice
(>year of age, (72)). To determine if RTE maturation was affected even earlier, we
performed similar analyses at 5-6 months of age. The data showed no delay in the
kinetics of maturation in control or K5.D1 RTEs (data not shown).
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Figure 22. Phenotypic RTE maturation in control and K5.D1 mice at 12 weeks of
age.
CD4 RTE maturation was identified in naïve T cells by the expression of (A) IL-7Rα,
(B) Qa-2 and (C) CD45RB in the GFPhi RTE, GFPlo RTE and GFPneg MN T cell subsets
of control and K5.D1 mice. CD8 RTE maturation was identified in naïve T cells by the
expression of (D) IL-7Rα, (E) Qa-2 and (F) CD45RB in the GFPhi RTE, GFPlo RTE and
GFPneg MN T cell subsets of control and K5.D1 mice. Data are representative of at
least 5 control or K5.D1 mice from four independent experiments.
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We assessed mean fluorescence intensity (MFI) to directly compare the level of
expression of IL-7Rα, Qa-2 and CD45RB on control and K5.D1 GFPhi, GFPlo and
GFPneg naïve T cells (Figure 23). The expression level of Qa-2 and CD45RB was
comparable between control and K5.D1 RTEs and MN T cells at each age analyzed.
We also found comparable levels of IL-7Rα expression on RTEs from control and
K5.D1 mice. Interestingly, however, we observed a significant increase in the MFI of IL7Rα expression on MN T cells from K5.D1 compared to control littermates at 12-16 and
20-24 weeks of age (Figure 23G-I). This finding suggests that increased IL-7Rα
expression on K5.D1 T cells may confer a survival advantage that promotes
persistence of MN T cells in the crowded K5.D1 periphery.

Functional Maturation of RTEs in Control and K5.D1 mice
In addition to changes in surface phenotype, RTEs undergo functional
maturation in the periphery as they progress to the MN T cell stage (117). Previous
studies have shown that CD4 RTEs from young mice do not proliferate or up-regulate
CD25 expression as extensively as MN T cells in response to anti-CD3 plus anti-CD28
stimulation in vitro in the presence of APCs (115, 132). Adding IL-2 to the cultures in
these studies did not correct this deficiency. Furthermore, RTEs produce less IL-2, IFNg and IL-4 than MN T cells. CD8 RTEs also are less competent than MN T cells in
proliferating and generating cytotoxic T cells in response to anti-CD3 stimulation in vitro
(115, 132).
Regardless of naïve T cell maturation status, previous studies have shown that
in general the responsiveness of naïve T cells to TCR stimulation is reduced with age
both in vitro and in vivo. (5, 112, 155-157). These studies have generally been
performed in young three month old mice and compared to >1 year old mice. However,
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little attention has been paid to potential defects in peripheral T cell immune function
during early stages of thymic involution. Thus, we asked two separate questions
regarding the functional maturation of RTEs from control and K5.D1 mice. First, we
wanted to know if RTE and/or MN T cell proliferation and cytokine production declines
during the first six months of life. Second, we wanted to compare these functional
parameters in RTEs and MN T cells from control and K5.D1 mice. We cultured FACS
sorted RTEs and MN T cells in the presence of APCs with anti-CD28 antibody and
varying amounts of anti-CD3 antibody. In agreement with previous reports, control
RTEs failed to produce as much IFNγ and IL-4 as control MN T cells when given
suboptimal doses of anti-CD3 regardless of whether the donors were 6 or 30 weeks of
age (Figure 24A and 11B, (132)). RTEs also failed to produce as much of these
cytokines at optimal doses of anti-CD3, showing that RTE are not as responsive as MN
T cells after TCR stimulation (data not shown). Proliferation of activated T cells was
assessed by CFSE label dilution. In agreement with a previous report, we found that
the frequency of proliferating control RTEs is less than MN T cells after stimulation
(Figure 24C and 24D, (132). Cytokine production and proliferation of K5.D1 RTEs and
MN T cells were comparable to controls RTE and MN T cells, respectively. These
results indicate that the cytokine and proliferative responses of RTEs and MN T cells
are comparable prior to and at early stages of thymus involution in both control and
K5.D1 mice.

K5.D1 MN T cells out-persist control MN T cells in a lymphoreplete environment
RTEs have been shown to compete poorly with MN T cells after competitive
adoptive transfer into a lymphoreplete environment, but out-persist MN T cells in a
lymphopenic host (113, 118). We have also observed similar disparities in RTE
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Figure 24. T cell activation occurs in K5.D1 T cells.
(A) IFNγ and (B) IL-4 expression after 72hr in vitro stimulation with 100ng anti-CD3 and
1ug anti-CD28. (C) Representative histograms of RTE and MN T cell CFSE dilution
72hr after in vitro stimulation using 100ng anti-CD3 and 1ug anti-CD28 antibody. (D)
The frequency of CFSE-diluting proliferative cells after stimulation. n≥3, *P<0.05,
**P<0.01 using a two-tailed paired Student T test.
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incorporation versus the MN T cells from control mice (data not shown). We questioned
whether K5.D1 RTEs and MN T cells could compete as well as their wildtype
counterparts for incorporation into a lymphoreplete periphery. To answer this question,
we mixed congenically marked control and K5.D1 CD4 RTEs or MN T cells at a 1:1
ratio and transferred them into unmanipulated, lymphoreplete recipients (Figure 25A).
We analyzed the injected cell mixture to obtain a precise ratio of control to K5.D1 cells
in order to compare the input ratio to the ratio of control and K5.D1 T cells recovered
from recipient spleen or lymph nodes (For example FACS data, see Figure 25B). This
approach facilitates comparisons among multiple experiments. A detailed description of
the calculations used in this adoptive transfer approach is presented in Chapter 2.
We found no competitive advantage in recovery of control and K5.D1 RTEs from
spleen, axial and inguinal lymph nodes at one or six weeks after transfer (Figure 26A).
These results imply that K5.D1 RTEs possess no overt survival characteristics relative
to control RTEs. However, K5.D1 MN T cells outcompeted control MN T cells as early
as one week as well as at six weeks post-transfer (Figure 26B).
The increased persistence of K5.D1 MN T cells suggested that they might
possess a survival advantage over their counterparts from control mice. Since we
observed increased expression of IL-7Rα on MN T cells from K5.D1 mice (Figure 23),
we hypothesized that IL-7 signaling might enhance their survival after adoptive transfer.
To test this, we FACS sorted MN T cells from control and K5.D1 mice and cultured
them in the presence or absence of IL-7 for up to 48 hours (Figure 26C). Both control
and K5.D1 T cells die rapidly without IL-7, with more than 70% of cells dying within 24
hours after being placed in culture (Figure 26C, solid points). When cultured in the
presence of IL-7, both control and K5.D1 T cell survival improved (Figure 26C, open
points). However, K5.D1 T cells survival was significantly higher at 24 and 48 hours
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Figure 25. Competitive adoptive transfer into lymphoreplete recipients.
(A) Experimental scheme to identify and adoptively transfer donor cells into
unmanipulated recipients. (B) Representative FACS plot identifying CD45.1 and
CD45.2 donor cells within a CD45.1/CD45.2 unmanipulated recipient CD4 splenic
naïve T cell pool.
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Figure 26. K5.D1 MN T cells out-persist control MN T cells in a lymphoreplete
environment.
(A) Recovery of K5.D1 vs. Control RTEs in the spleen, axial and inguinal LNs of
recipient mice after 1 or 6wk after transfer. (B) Recovery of K5.D1 vs. Control mature
naïve (MN) T cells in the spleen, axial and inguinal LNs of recipient mice after 1 or 6wk
after transfer. (C) Survival Assay of control or K5.D1 T cells cultured in the presence or
absence of 5ng IL-7. n≥3, *P<0.05 and **P<0.01 using a two-tailed unpaired Student T
test or paired Student T test (Figure C).
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than control T cells when IL-7 was supplemented. Interestingly, these differences were
neutralized when cells were cultured in the presence of higher concentrations of IL-7.
Therefore, our results suggest that the increased IL-7Rα expression does play a role in
K5.D1 T cell survival.

T cell receptor diversity is maintained in K5.D1 mice
Naïve T cell TCR repertoire diversity is severely altered in aged mice, and stems
from the decline in RTE output and homeostatic proliferation of peripheral T cells (1, 3).
Because we observed significant changes in the frequency of naïve T cells in control
mice as early at 12-16 weeks of age, we wanted to determine if TCR repertoire
diversity was impacted by this decline. We addressed this question by assaying the
usage frequency of fifteen different TCR Vβ segments that can make up the CDR3
region of the TCR beta chain (Figure 27). Using an antibody panel, and FACS analysis,
we did find slight alterations in the frequencies of some Vβs with age, including Vβ4,
Vβ8.1/8.2, and Vβ10b in the CD4 naïve subset and Vβ5.1/5.2 in the CD8 naïve T cell subset of
control mice. However, K5.D1 mice exhibited similar changes in the usage of these
same Vβ regions, indicating that declining T cell output in control mice did not drive
these changes.
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4.3

Discussion
Age-associated changes in the T cell pool that result from severe thymus

involution have been investigated in mice over one year of age. These studies
concluded that thymus involution is associated with severe impairment in T cell immune
responses (76, 134, 165, 166). Here we show that the earliest phases of thymus
involution initiate the age-associated shift from naïve to memory cell dominancy within
the T cell pool. Declining RTE output is evident by 12-16 weeks of age in the control
mice from our studies, resulting in decreased naïve T cell numbers. The naïve T cell
loss from these events is filled by the generation of memory T cells to maintain the
cellularity of the T cell pool.
There has been much speculation that preventing thymus involution is an
important goal to sustain naïve T cell output and robust immune response capabilities.
Expression of the K5.D1 transgene in TECs prevents thymus involution and increases
RTE output with age. Moreover, the K5.D1 RTEs do not impede the establishment of
the mature naïve T cell subset. Not all of these RTEs survive to the MN T cells stage.
However, enough survive to result in a significantly increased number of MN T cells at
20-24 weeks of age compared to controls in which MN T cell numbers have declined at
that point. Thus, maintaining a functional thymus translates into preventing the loss of
MN T cells, which are required to generate T cell immune responses to newly
encountered antigens.
The crowded K5.D1 naïve T cell pool does not impact the generation of memory
T cell subsets, supporting previous speculation that the naïve and memory T cell
populations reside in separate niches in the periphery. We conclude that sustaining T
cell output maintains large numbers of naïve T cells that prevent the age-associated
shift from naïve to memory dominancy in the T cell pool.
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The kinetics of RTE maturation have been shown to slow with age (72). We
found no significant difference in RTE maturation in control mice 4 to 24 weeks of age.
This result suggests that early involution does not alter RTE maturation. We also
observed comparable RTE maturation in K5.D1 mice up to 24 weeks of age.
Interestingly, IL-7Ra expression was increased on MN T cells from K5.D1 mice. This
result suggested that K5.D1 MN T cells might be more apt to survive via IL-7 signaling
in lymphoreplete conditions. Indeed K5.D1 MN T cells out-persisted control MN T cells
at a three to one ratio in adoptive transfer experiments.
Naïve T cell homeostasis requires critical factors including the availability of IL-7
and MHC. Although we do not yet know if IL-7 signaling mediates the enhanced
survival observed in vivo, the in vitro survival studies demonstrated that K5.D1 T cells
do survive better than control cells in low concentrations of IL-7. We speculate that the
increased number of T cells in K5.D1 mice drives down the availability of IL-7 on a per
cell basis. The expression of IL-7R has been shown to increase during times of low IL-7
availability, and is rapidly downregulated upon ligand-receptor interaction (Reviewed in
(110). Therefore, we suspect that low levels of IL-7 availability in the K5.D1 periphery
may lead to the increased IL-7R expression observed on K5.D1 MN T cells. Then,
when these cells are transferred into a wildtype lymphoreplete recipient, they are better
poised to interact with available IL-7 and persist than wildtype cells.
TCR diversity is essential for maintaining robust primary immune responses. Our
data show that TCR activation in K5.D1 T cells is comparable to control T cells up to 30
weeks of age. Furthermore, TCR diversity, as assayed by Vβ usage frequency shows
no clonal expansion of any particular TCR in K5.D1 mice. These results support our
notion that the K5.D1 thymus sustains the generation of diverse and responsive T cells.
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Taken together, the work presented throughout this chapter support our hypothesis that
preventing involution sustains a large, responsive naïve T cell pool.
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CHAPTER FIVE
DISCUSSION

The negative influence of thymus involution on the peripheral T cell pool has
been established in both mouse and man. As the thymus atrophies, thymopoiesis is
reduced and the output of naïve T cells declines. This deficit in the production and exit
of naïve T cells leads to peripheral T cell proliferation to maintain peripheral
homeostasis. The naïve to memory T cell ratio declines as a consequence, and this
age and involution-associated trend is associated with restricted TCR diversity and
defects in the ability to mount protective immune responses to newly encountered
antigens (1, 134).
Thymus involution is driven primarily by disintegration of the TEC compartment
(57, 81, 147). Therefore we chose to determine whether preventing the loss of TECs
ablated involution and peripheral T cell pool dynamics. Previously our lab showed that
the TEC microenvironment is maintained in K5.CyclinD1 (K5.D1) mice, which in turn
sustained thymopoiesis (135, 143). We became particularly interested in determining
how early stages of thymus involution affect the composition of the peripheral T cell
pool. Most studies of involution concentrated on thymi from old (1 to 2 years of age)
mice that are completely atrophied. Thus, changes in the composition and function of
peripheral T cells in very old mice measure end stage effects. However, we and others
have shown that thymus involution actually is initiated early in life (57, 141). Therefore,
we undertook this study to determine: 1) the consequences of early stage involution on
peripheral T cells and 2) whether involution-associated defects in peripheral T cells
would be averted in K5.D1 mice that do not undergo thymus involution.
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Our investigations have resulted in four significant findings: First, we showed
that increased Foxn1 expression is associated with sustained TEC numbers and
differentiation, which helps to sustain the functional microenvironment necessary for
continued thymopoiesis with age. Second, we found that early thymus involution in
control mice precipitates a decline in RTEs that initiates an early age-associated shift
toward memory T cell dominancy evident in aged mice and elderly patients. Third, we
showed that the absence of thymus involution prevents age-associated changes to the
composition of the T cell pool without inhibiting the generation of memory T cells.
Fourth, we demonstrated that K5.D1 MN T cells have a competitive advantage over
nontransgenic MN T cells in adoptive transfer studies. These results demonstrate that
maintenance of the TEC microenvironment is essential not only for continued
thymopoiesis, but also for the sustaining a large and diverse naïve T cell population.

Foxn1 expression is maintained indefinitely in K5.D1 TECS
The FOXN1 transcription factor has been heralded as the ‘master regulator’ of
TEC maintenance and differentiation in both fetal and postnatal thymi. To this end,
multiple groups have reported that early termination of Foxn1 expression results in
premature involution (81, 167), whereas the maintenance of Foxn1 expression slows
but does not prevent involution (82). These previous findings demonstrated that
maintenance of the TEC microenvironment requires Foxn1 expression, likely in concert
with other factors. The fact that thymopoiesis relies on interactions with a welldifferentiated TEC microenvironment to produce competent T cells reinforces the close
relationship between TEC degeneration and diminished thymopoiesis during thymus
involution. Our data in Chapter Three revealed that TECs from young K5.D1 mice
express elevated levels of Foxn1 expression compared to control littermate TECs. With
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age, the high level of Foxn1 expression in K5.D1 TECs is maintained in stark contrast
to TECs from age-matched wildtype mice, which lose Foxn1 expression with the onset
of thymus involution.
While Foxn1 expression does not account solely for the increased number of
TECs and avoided involution in K5.D1 thymi, it does suggest that Cyclin D1 expression
has an important influence on preserving steady-state signaling conditions in aging
TECs. It remains to be determined if the K5.D1 transgene exerts a direct or indirect role
in maintaining the Foxn1 expression, although another experimental mouse model
employing the same cell cycle pathway was shown to directly influence transcription of
Foxn1 in TECs. Work from Garfin and colleagues showed that knocking out Rb, the
downstream target of the CyclinD1/Cdk heterodimer, de-repressed the E2F
transcription factor family to allow binding of E2F3 to the Foxn1 promoter. While
investigation of this mechanism was not pursued in our studies and may not fully
explain the K5.D1 phenotype, we speculate that this same pathway likely plays a role in
the increased Foxn1 expression observed. Furthermore, the K5.D1 TEC compartment
is well organized into differentiated cTEC and mTEC subsets. This finding is consistent
with other studies in which thymus size was maintained or rebounded when Foxn1
expression was driven in TECs (82, 83, 152). In these models increased Foxn1
expression promoted crucial TEC differentiation that supports thymopoiesis and
continued T cell output. Thus, these data and our own support the central dogma that
maintaining Foxn1 expression is a key factor in the sustaining both a differentiated TEC
microenvironment and continued thymopoiesis past the time frame of normal ageassociated involution.
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The K5.D1 TEC microenvironment supports thymopoiesis and sustains the output of
self-tolerant RTEs with age
We previously reported a normal frequency of major thymocyte subsets in K5.D1
mice. In that same report, positive and negative selection were shown to be intact in
mice that expressed the K5.D1 transgene as well as the H-Y TCR transgene (135).
Since the H-Y TCR is expressed on DN thymocytes, a developmental stage in which
TCRs are not yet expressed in wildtype mice, we performed additional studies to
assess selection in the K5.D1 TEC environment for this thesis. Our data showed that
that the percentage of post-positive selection (CD69+) DP thymocytes was comparable
to that in nontransgenic controls. We also determined that the strength of TCR
engagement on K5.D1 DP thymocytes is comparable to controls by means of Nur77
and CD5 expression. These findings support our previous work indicating that positive
selection in K5.D1 thymi is indistinguishable from that in control littermates. We
performed a more thorough analysis of negative selection and demonstrated that
serum from K5.D1 mice did not contain detectable autoantibodies. Moreover,
transferring K5D1 T cells into RAG2-/- recipients that cannot generate Tregs failed to
produce autoimmune symptoms. Considering that the TEC microenvironment is
instrumental for negative and positive selection, and is maintained in K5.D1 mice, these
results confirm that the K5.D1 model is an excellent tool for studying how the absence
of thymus involution affects peripheral T cells with age without skewing TCR diversity
toward autoimmunity.
The precursors for all subsequent stages of thymocyte development are the ETP
subset, which have been shown to decline with age and involution (149, 168). Our
results from control mice agree with these published findings. Interestingly, preventing
thymus involution in K5.D1 mice maintains ETP cellularity, and suggests that the K5.D1
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TEC microenvironment continues to provide available intrathymic niches necessary to
support ETP survival and differentiation with age. Furthermore, the fact that TEC
cellularity increases with age in the K5.D1 thymus, whereas the number of TECs in
control nontransgenic thymi decreases with age supports the premise that the TEC
microenvironment is necessary for ETP survival and persistence.
Our data agrees with a previous report showing that thymic output is dependent
on organ size. (72). The ratio of RTEs to DP thymocytes is relatively stable in control
and K5.D1 mice with age. This demonstrates that the amount of RTEs in the periphery
is a function of the size of the developing thymocyte pool.

Thymus egress is delayed in K5.D1 mice
Thymus emigration is the final step of thymopoiesis, and is a highly controlled
process to prevent the escape of immature or autoreactive T cells. Unexpectedly, we
observed an accumulation of late stage SP thymocytes in K5.D1 mice that increased
with age. We determined that proliferation and maturation could not account for the
observed phenotype. Importantly, the late SP stage is the last maturation step before
thymus emigration. To prevent immature thymocytes from emigrating, the early
activation marker CD69 is expressed after TCR engagement on SP cells. CD69
expression stalls cells that require additional maturation by preventing the expression
of KLF2 target genes necessary for exit, including CD62L and S1P1R (169). We
observed appropriate downregulation of CD69, as well as expression of CD62L on
K5.D1 thymocytes, which confirmed that SP thymocytes were undergoing maturation
and preparing for thymus emigration. Furthermore, we found that late stage SP
thymocytes were actually retained longer in K5.D1 mice than littermate controls by
using the intensity of RAG2p-GFP signal as an indicator of the length of thymus
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residency. While altered S1P1R expression cannot be fully dismissed as the cause of
the retained K5.D1 SP cells, we did not observe any accumulation of cells in the
perivascular spaces that would suggest low S1P1R expression. Interestingly, there are
multiple mouse models that display late stage SP retention much like the K5.D1 model,
including S1P1R-/- Aire-/-, PI3K-/- and SOCS1-/- mice (46, 170-172). The similarities
between these models and our own suggest additional avenues that should be
considered for determining the mechanism behind this K5.D1 phenotype. These
include altered chemokine/receptor expression, as well as minor defects in negative
selection that our studies have not exposed. Thus, further investigation is necessary to
determine the mechanistic underpinnings of accumulating late stage thymocytes in the
aging K5.D1 thymus.

Thymic Treg generation versus recirculation
The generation of Tregs is essential for the suppression of inflammatory and
autoreactive T cells in the periphery. We observed an increased frequency of Tregs in
the K5.D1 thymus with age. However, we did not find an increased frequency of Tregs
in the periphery. We initially speculated that increased thymopoiesis in the K5.D1
thymus might lead to increased numbers of thymocytes undergoing apoptosis due to
negative selection, which has been reported to promote the apoptosis-TGFβ-Foxp3
axis to induce Treg generation (173). However, a recent publication has highlighted the
tendency of peripheral Tregs to recirculate into the thymus, thus artificially inflating
thymic Treg frequency (153). Therefore we cannot definitively say whether the
increased frequency of thymic Tregs in K5.D1 mice is due to generation or
recirculation. In an attempt to determine whether the phenotype was due to de novo
Treg generation or peripheral Treg circulation we utilized the RAG2p-GFP reporter to
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identify newly generated Tregs. Unfortunately, our current method of Foxp3
identification relies on cell fixation and analysis of Foxp3 transcription factor expression
by flow cytometry, which completely destroyed GFP signal in our preliminary
experiments. In order to visualize Tregs in K5.D1 mice, either a third transgene for
Foxp3 identification would need to be utilized in our RAG2p-GFP system, or Tregs from
congenically distinct mice could be injected into K5.D1 mice and analyzed after a chase
period to determine the rate of Treg homing to the thymus. Nonetheless, the
implications from either increased Treg generation or peripheral recirculation will impact
the characterization of this mouse model, and which might prove the K5.D1 model
useful for Treg studies in the future.

Early thymus involution in young mice precipitates age-associated changes in the
composition of peripheral T cells
Age-associated changes to the composition of the T cell pool have been defined
in both aged mice and elderly patients. Our studies focused on the ramifications of
early thymus involution on the peripheral T cell pool, and revealed that early stages of
involution promote changes to the frequency and number of naïve and memory T cells.
Furthermore, we were able to show that these changes are due to reduced RTE output
by involuting thymi that fails to sustain naïve T cell numbers. To our knowledge, this is
the first description of the influence early thymus involution has upon the established T
cell pool in young mice. Furthermore, our data contradicts popular opinion regarding
when naïve T cell numbers decline (134), and shows that this occurs much earlier than
previously appreciated.
In stark contrast to the decreased ratio of naïve to memory peripheral T cells in
nontransgenic controls during early involution, the pre-involution ratio of naïve to
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memory cells was maintained in K5.D1 mice due to sustained RTE production. This
finding agrees with reports of other mouse models in which the TEC microenvironment
and thymopoiesis are sustained or regenerated at older ages, thus maintaining or
reversing the shift between naïve and memory T cell dominancy (82, 83, 152).
Importantly, the number of K5.D1 MN T cells is nearly double that of control MN T cells
by just 12-16 weeks of age. This result suggests that the periphery can accommodate a
limited increase in T cell number despite the homeostatic control that normally
preserves a relatively constant number of cells in the periphery. The fact that the
increase in naïve peripheral T cells does not mirror the increase in thymocytes
suggests that homeostatic signals are limiting. Previous studies have shown that the
major signals regulating homeostasis of naïve T cells include IL-7 and MHCII
(Reviewed in (106, 109, 110, 159)). However, homeostatic cytokine signaling cannot
support an indefinite amount of cells, as evidenced by our findings. In support of this
concept, transplantation of up to nine thymic lobes under the kidney capsule of wildtype
mice only leads to a doubling of the size of the T cell pool (158).
We also found that the increase of naïve T cells in K5.D1 mice did not impact the
number of memory T cells. This agrees with previous speculation that naïve and
memory T cell populations occupy distinct niches within the peripheral T cell pool (174).
Indeed, naïve T cell numbers are largely controlled by IL-7 and MHC interactions,
whereas memory T cell numbers are sustained by a combination of IL-7 and IL-15
(Reviewed in (106, 109, 110, 159)). Therefore, the loss of naïve T cell numbers with
age is not a necessary prerequisite to create room for antigen-experienced memory T
cells, but occurs solely as a consequence of thymus microenvironmental degeneration
for naive T cell output. Whether the continual output of naïve T cells impacts the longterm response of memory T cells in our K5.D1 mice remains to be seen. The memory T
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cell population should be investigated to determine whether the continual output of
naïve T cells affects the clonal diversity, longevity and response of the memory T cell
population.

The relationship between RTEs and MN T cells
Since the naïve T cell population consists of both phenotypically and functionally
distinct RTEs and MN T cells, we analyzed these subsets through the use of the
RAG2p-GFP transgenic mouse model. Interestingly, the frequency of GFP hi and GFPlo
RTEs in K5.D1 mice was much higher than in controls. While in controls a low
frequency of GFPhi RTEs gave way to a higher frequency of GFPlo RTEs that
maintained the MN T cell population, this was not the case in K5.D1 mice. Although the
frequency of GFPhi RTEs was lower than GFPlo RTEs, the MN T cell subset in K5.D1
mice was much smaller than the GFPlo RTE subset. This demonstrates that the excess
RTEs that are produced by the K5.D1 thymus do not survive for more than ~3 weeks in
the periphery. We do not have direct evidence that most GFPlo RTEs undergo
apoptosis. However, others have shown that RTEs do not incorporate into a
lymphoreplete environment as well as MN T cells, perhaps due to a reduced ability to
respond to homeostatic signals, (118). Therefore, K5.D1 RTEs may undergo apoptosis
due to limited availability of homeostatic signals in the periphery.
Notably, IL-7Rα expression was increased on K5.D1 MN T cells compared to
control T cells. We speculate that the increased number of naïve T cells in the K5.D1
periphery is indirectly responsible for the increased IL-7Rα expression on MN T cells.
Expression of IL-7Rα is modulated by IL-7 availability (Reviewed in (110)). Thus IL-7Rα
expression is increased in the presence of low levels of IL-7, whereas IL-7Rα
expression declines on T cells in higher concentrations of IL-7. The cyclical regulation
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of the IL7-Rα is thought to improve the likelihood of ligand interaction when IL7
availability is low. IL7-IL7R interaction promotes receptor internalization and
transcriptional downregulation, which is thought to conserve IL-7 ligand for interactions
with a larger fraction of T cells so as to support homeostasis of the entire population
(110, 175). Because the K5.D1 mouse contains nearly three times the number of T
cells present in littermate controls, we speculate that the availability of IL-7 for any one
cell is greatly reduced. Therefore, we suspect that low IL-7 availability promotes
increased IL-7Rα expression on K5.D1 T cells, which in turn promotes cellular survival
in the crowded K5.D1 periphery.
We tested the survival capabilities of K5.D1 MN T cells by directly competing
these cells with control MN T cells in an adoptive transfer experiment using
lymphoreplete recipients. These experiments demonstrated that K5.D1 MN T cells outpersist control T cells in a lymphoreplete environment, and suggests that the K5.D1 T
cells have an inherent survival or proliferative advantage compared to control T cells in
this system. This, coupled with the increased IL-7Rα expression present on K5.D1 MN
T cells, led us to speculate that the IL-7 signaling pathway plays a role in sustaining the
K5.D1 MN T cells in vivo. Our short-term in vitro culture results suggests that increased
IL-7Rα expression on K5.D1 T cells does, in fact, promote the viability of these cells.
We also performed additional IL-7 culture experiments that demonstrated enhanced
proliferation does not account for K5.D1 MN T cell persistence in vitro (data not
shown). While additional factors that promote T cell persistence cannot be ruled out,
including increased cell lifespan and the support of other homeostatic cytokines, the
enhanced survival of MN T cells in the presence of IL-7 is consistent with the notion
that IL-7Rα expression plays an important role in supporting MN T cell homeostasis in
the K5.D1 periphery.
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Preventing involution: beneficial or detrimental?
There is little question that thymopoiesis is a biologically expensive process, with
only 1-2% of all thymocytes completing maturation and exiting the thymus. This leads
some immunologists to speculate that the involution process is an evolutionarily
conserved attempt to curb the energy-expensive production of T cells after T cell pool
has been established (176). However, there has been no established feedback loop
between the periphery and thymus to account for this hypothesis. Nonetheless, there is
a strong correlation between increasing thymus atrophy and the onset of puberty,
which supports the idea that metabolic resources are diverted toward reproduction at
the expense of T cell development to ultimately support the persistence of the species
(176). Still others believe that the involution process represents biological adaptation at
work. Since the life expectancy in developed countries has nearly doubled since the
industrial revolution, perhaps the sustainment of thymus size has not yet adapted to the
increased human lifespan. Whether thymus involution is evolutionarily driven or
represents ongoing adaptation remains to be seen, but does not negate the fact that T
cell-mediated immune responses decline significantly with age.
Adverting or reverting thymus involution has been suggested as a remedy for
many of the age-related defects in T cell production and response. The research
presented herein supports this view and show that a large and diverse T cell pool can
be maintained by preventing TEC-driven thymus involution. However, our studies were
not conducted beyond the age of six months due to the physical constraints of the
mouse model, and therefore leaves unanswered the question of whether maintaining
thymus size into old age is beneficial or detrimental to immune function. There has
been speculation that thymus involution is necessary to prevent the development of a
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large autoimmune T cell population with age (77). This perspective stems from the
correlation between the skewed TRA expression observed in TECs from aged,
involuted thymi and the increased numbers of autoimmune T cells escaping selection in
these thymi. Furthering this idea, thymic regeneration in mice fails to restore the TEC
microenvironment and expression of TRAs after involution (177). Thus, the thought is
that T cells produced in a regenerated thymus are likely to respond suboptimally and
may even promote autoimmunity. Both of these observations have been made in
involuted thymi but have not addressed the TRA situation in thymi that have avoided
involution. Studies utilizing would put to bed this disagreement among the immunology
field and clarify the help or harm a productive thymus can deliver to the aging immune
system.
We’ve shown that even early thymus involution has a significant consequence
on the size and composition of the naïve T cell population, which is essential for
recognizing newly encountered antigens. Our results suggest that preventing thymus
involution is truly central to preventing age-associated changes to the peripheral T cell
pool. Furthermore, the T cells derived from the non-involuting K5.D1 thymus appear to
be normal – there are no apparent defects in negative or positive selection of K5.D1
thymocytes, TCR diversity is maintained and the RTEs generated from the K5.D1
thymus undergo appropriate phenotypic and functional maturation in the periphery.
Though K5.D1 mouse model is highly artificial, it proves that sustaining the thymic
microenvironment is central to maintaining competent T cell output. Whether preventing
the loss and diversity of TEC subsets adverts the skewing of TRAs expressed in the
thymus remains to be seen.
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Final Thoughts
The K5.D1 model serves as a useful tool for investigating the mechanisms
responsible for loss of the TEC compartment during the stages of thymus involution.
The next major question that should be answered by this model is whether preventing
thymus involution enhances the T cell response to pathogen and tumor antigens
throughout the lifespan. The implications from this work, whether positive or negative,
would help shape the field’s viewpoint on the benefits involution prevention and thymic
regeneration can bring to the table as a potential therapeutic approach.

133

APPENDIX 1
AGED K5.D1 HISTOPATHOLOGY
Control and K5.D1 animals were aged to 6-8 months and necropsied to
determine what, if any, autoimmunity occurred as a consequence of the K5.D1
transgene. The following representative images and histopathology report demonstrate
that K5.D1 T cells do not promote autoimmunity in the peripheral organs. Furthermore,
these studies have been replicated at least three separate times, with three or more
control and K5.D1 replicates within each study. Therefore, we are confident that
thymus hyperplasia in the K5.D1 transgenic mouse does not promote systemic
autoimmunity.
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Animal
Slide
#
#
2592 WT 1

Tissue

Diagnosis

Liver

2592 WT 1
2592 WT 2

Kidney
Small intestine

2592 WT 2
2592 WT 3

Large intestine
Salivary gland

2592 WT 3
2592 WT 3
2592 WT 4
2592 WT 4
2593 WT 1

Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Liver

Triaditis, lymphocytic, multifocal, minimal
EMH, focal, minimal
NSL
Lamina propria - NSL
Peyer’s patch - NP
Lamina propria - NSL
Sialoadenitis, lymphoplasmacytic,
multifocal, moderate
NSL
Adenitis, lymphocytic, multifocal, mild

2593 WT 1

Kidney

2593 WT 2

Small intestine

2593 WT
2593 WT
2593 WT
2593 WT

2593 WT 4
2593 WT 4
2594 WT 1

Large intestine
Salivary gland
Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Liver

2594 WT 1
2594 WT 2

Kidney
Small intestine

2594 WT
2594 WT
2594 WT
2594 WT

2
3
3
3

2594 WT
2594 WT
2595 D1
2595 D1

4
4
1
1

Large intestine
Salivary gland
Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Liver
Kidney

2595 D1

2

Small intestine

2
3
3
3

NSL
NSL
Triaditis, lymphocytic, multifocal, minimal
EMH, multifocal, minimal
ISN, lymphoplasmacytic, multifocal,
moderate
Lamina propria - lymphoid hyperplasia,
minimal
Peyer’s patch - NSL
Lamina propria - NSL
Sialoadenitis, lymphocytic, focal, mild
Lymphoid hyperplasia, mild
Adenitis, lymphocytic, multifocal, moderate
Pancreatitis, lymphocytic, focal, mild
NSL
Triaditis, lymphocytic, multifocal, minimal
Vacuolar change, centrilobular, focally
extensive, moderate
ISN, lymphoplasmacytic, multifocal, mild
Lamina propria – lymphoid hyperplasia,
minimal
Peyer’s patch - NSL
Lamina propria - NSL
Sialodenitis, lymphocytic, multifocal, mild
Section too small to evaluate
Adenitis, lymphocytic, multifocal, mild
NSL
NSL
Triaditis, lymphocytic, multifocal, minimal
ISN, lymphoplasmacytic, multifocal,
minimal
Lamina propria – lymphoid hyperplasia,
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2595 D1
2595 D1
2595 D1
2595 D1

2
3
3
3

2595 D1
2595 D1
2596 WT
2596 WT

4
4
1
1

Large intestine
Salivary gland
Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Liver
Kidney

2596 WT 2

Small intestine

2596 WT 2
2596 WT 3

Large intestine
Salivary gland

2596 WT 3
2596 WT 3

Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Liver
Kidney
Small intestine

2596 WT
2596 WT
2597 D1
2597 D1
2597 D1

4
4
1
1
2

2597 D1
2597 D1
2597 D1
2597 D1

2
3
3
3

2597 D1
2597 D1
2598 D1

4
4
1

Large intestine
Salivary gland
Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Liver

2598 D1

1

Kidney

2598 D1

2

Small intestine

2598 D1
2598 D1
2598 D1
2598 D1

2
3
3
3

2598 D1

4

Large intestine
Salivary gland
Cervical l.n.
Extraorbital
lacrimal gland
Pancreas

mild
Peyer’s patch – lymphoid hyperplasia,
minimal
Lamina propria - NSL
NSL
Not present on slide
Adenitis, lymphocytic, multifocal, moderate
NSL
NSL
Pyogranulomas, multiple, minimal
ISN, lymphoplasmacytic, multifocal, mild
Hydronephrosis, mild, unilateral
Lamina propria - NSL
Peyer’s patch - not present on slide
Lamina propria - NSL
Sialoadenitis, lymphoplasmacytic,
multifocal, moderate
Lymphoid hyperplasia, mild
Adenitis, lymphocytic, multifocal, mild
NSL
NSL
Triaditis, lymphocytic, multifocal, minimal
ISN, lymphocytic, multifocal, minimal
Lamina propria - NSL
Peyer’s patch – lymphoid hyperplasia, mild
Lamina propria - NSL
NSL
NSL
Adenitis, lymphocytic, multifocal, mild
NSL
NSL
Triaditis, lymphocytic, multifocal, mild
Bile duct hyperplasia, multifocal, mild
ISN, lymphocytic, multifocal, mild
Malformation of pelvis with focal epithelial
hyperplasia, bilateral, moderate
Lamina propria - NSL
Peyer’s patch – lymphoid hyperplasia, mild
Lamina propria - NSL
Sialoadenitis, lymphocytic, multifocal, mild
Lymphoid hyperplasia, moderate
Adenitis, lymphocytic, multifocal, moderate
NSL
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2598 D1

4

Skin

NSL

Comment:
Triaditis and lymphoid hyperplasia of lamina propria are within normal limits.
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APPENDIX 2
RAG2-/- T CELL RECIPIENT HISTOPATHOLOGY
To determine peripheral environment dampens the extent of autoreactivity of T
cells from K5.D1 mice, we injected FACS sorted CD4 T cells from control or K5.D1
mice into immunocompromised recipients. These mice were weighed every other day
for three weeks and necropsied. A blind pathological reading of slides from multiple
organs did not reveal any lymphocyte infiltrates or other signs of autoreactivity in
recipients. Presented below are representative images from RAG2-/- recipients that
received control or K5.D1 T cells, as well as the final histopathology report created by
Dr. Donna Kusewitt. Taken together, we conclude that K5.D1 T cells do not possess
the potential for autoreactivity.
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K5.D1
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Pancreas
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FINAL REPORT
Necropsy/Histopathology Report
MM
PS #
679
INVESTIGATOR:
Ellen
Richie
SUBMITTOR:
Michelle Bolner DATE
SUBMITTED: 5/7/15
DATE COMPLETED:
5/12/15
Microscopic Findings:
Animal #
Slide Tissue
#
WT 1L
2613 - Liver
1
WT 1L
1
Kidney
WT 1L
2
Small intestine
WT 1L
WT 1L
WT 1L
WT 1L
WT 1L
WT 1L
WT 1L
WT 1L
WT 1L
WT 2R
WT 2R
WT 2R
WT 2R
WT 2R
WT 2R
WT 2R
WT 2R
WT 2R
WT 2R

Diagnosis
NSL

ISN, lymphocytic, focal, mild
Lamina propria - NSL
Peyer’s patch - NP
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
Lymphoid hypoplasia, marked
3
Extraorbital
NSL
lacrimal gland
4
Pancreas
NSL
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, moderate
EMH, moderate
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
6
Lung
NSL
2614 - Liver
NSL
1
1
Kidney
ISN, lymphocytic, focal, mild
2
Small intestine Lamina propria - NSL
Peyer’s patch - NP
2
Large intestine Lamina propria - NSL
3
Salivary gland Sialoadenitis, lymphoplasmacytic, multifocal,
moderate
3
Cervical l.n.
NSL
3
Extraorbital
Adenitis, lymphocytic, multifocal, mild
lacrimal gland
4
Pancreas
NSL
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, marked
EMH, moderate
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WT 2R

5

Thymus

WT 2R
WT 3B

6
2615 1
1
2

Lung
Liver

WT 3B
WT 3B
WT 3B
WT 3B
WT 3B
WT 3B
WT 3B
WT 3B
WT 3B
WT 3B

WT 3B
WT 9L
WT 9L
WT 9L

WT 9L
WT 9L
WT 9L
WT 9L
WT 9L
WT 9L
WT 9L
WT 9L
WT 9L
D1 4 2R
D1 4 2R

Hypoplasia, moderate, with no cortico-medullary
demarcation
Cyst, epithelial
PB/PV, lymphocytic, focal, minimal
Triaditis, lymphocytic, multifocal, minimal

Kidney
NSL
Small intestine Lamina propria - NSL
Peyer’s patch – Lymphoid hypoplasia, marked
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
NP
3
NSL
Extraorbital
lacrimal gland
4
Pancreas
NSL
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, moderate
EMH, mild
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
Cysts
6
Lung
PB/PV, lymphocytic, multifocal, moderate
(lung not fully expanded)
2621 - Liver
Triaditis, lymphocytic, multifocal, mild
1
1
Kidney
ISN, lymphocytic, multifocal, minimal
2
Small intestine Lamina propria – enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch – lymphoid hypoplasia, marked
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
Lymphoid hypoplasia, moderate
3
NSL
Extraorbital
lacrimal gland
4
Pancreas
Pancreatitis (periductal), lymphocytic, multifocal,
minimal
4
Skin
Folliculitis, lymphocytic, multifocal, minimal
5
Spleen
Lymphoid hypoplasia, moderate
EMH, marked
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
6
Lung
PB/PV, lymphocytic, multifocal, mild
2616 - Liver
Triaditis, lymphocytic, multifocal, mild
1
Microgranuloma, single, minimal
1
Kidney
NSL
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D1 4 2R

D1 4 2R
D1 4 2R
D1 4 2R
D1 4 2R
D1 4 2R
D1 4 2R
D1 4 2R
D1 4 2R
D1 4 2R
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N
D1 5N

D1 5N
D1 6R
D1 6R
D1 6R

D1 6R
D1 6R
D1 6R
D1 6R

Small intestine Lamina propria – enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch – lymphoid hypoplasia, moderate
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
Lymphoid hypoplasia, moderate
3
Extraorbital
Adenitis, lymphocytic, multifocal, mild
lacrimal gland
4
Pancreas
Pancreatitis (periductal), lymphocytic, multifocal,
mild
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, moderate
EMH, moderate
5
Thymus
Hypoplasia, marked, with no cortico-medullary
demarcation
6
Lung
PB/PV, lymphocytic, multifocal, moderate
2617 - Liver
Triaditis, lymphocytic, multifocal, mild
1
1
Kidney
ISN, lymphocytic, focal, mild
2
Small intestine Lamina propria – NSL
Peyer’s patch – NP
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
Lymphoid hypoplasia, moderate
3
Extraorbital
NSL
lacrimal gland
4
Pancreas
NSL
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, moderate
EMH, moderate
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
Cysts, multiple
6
Lung
PB/PV, lymphocytic, multifocal, minimal
2618 - Liver
Triaditis, lymphocytic, multifocal, minimal
1
1
Kidney
ISN, lymphocytic, multifocal, mild
2
Small intestine Lamina propria – enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch – NP
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
NP
3
Adenitis, lymphocytic, multifocal, marked
Extraorbital
lacrimal gland
2
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D1 6R
D1 6R
D1 6R

4
4
5

Pancreas
Skin
Spleen

D1 6R

5

Thymus

D1 6R
D1 7B

6
2619 1
1
2

Lung
Liver

D1 7B
D1 7B

D1 7B
D1 7B
D1 7B
D1 7B
D1 7B
D1 7B
D1 7B
D1 7B
D1 7B
D1 10R
D1 10R
D1 10R

D1 10R
D1 10R
D1 10R
D1 10R
D1 10R
D1 10R
D1 10R
D1 10R
D1 10R
D1 11B

NSL
Perifolliculitis, lymphocytic, multifocal, mild
Lymphoid hypoplasia, marked
EMH, marked
Hypoplasia, moderate, with no cortico-medullary
demarcation
PB/PV, lymphocytic, multifocal, moderate
Triaditis, lymphocytic, multifocal, minimal

Kidney
NSL
Small intestine Lamina propria – enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch – lymphoid hypoplasia, marked
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
Lymphoid hypoplasia, marked
3
Adenitis, lymphocytic, multifocal, minimal
Extraorbital
lacrimal gland
4
Pancreas
NSL
4
Skin
Folliculitis, lymphocytic, focal, minimal
5
Spleen
Lymphoid hypoplasia, marked
EMH, marked
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
6
Lung
PB/PV, lymphocytic, multifocal, minimal
2622 - Liver
Hepatitis, pyogranulomatous, multifocal, marked
1
1
Kidney
ISN, lymphocytic, multifocal, mild
2
Small intestine Lamina propria- enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch – lymphoid hypoplasia, moderate
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
NP
3
NSL
Extraorbital
lacrimal gland
4
Pancreas
NSL
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, moderate
EMH, marked
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
6
Lung
PB/PV, lymphocytic, multifocal, mild
2623 - Liver
Triaditis, lymphocytic, multifocal, minimal
1
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D1 11B
D1 11B

D1 11B
D1 11B
D1 11B
D1 11B
D1 11B
D1 11B
D1 11B
D1 11B
D1 11B
PBS 8 2R
PBS 8 2R
PBS 8 2R

PBS 8 2R
PBS 8 2R
PBS 8 2R
PBS 8 2R
PBS 8 2R
PBS 8 2R
PBS 8 2R
PBS 8 2R

PBS 8 2R
PBS 12 2L
PBS 12 2L
PBS 12 2L

PBS 12 2L

1
2

Kidney
NSL
Small intestine Lamina propria- enteritis, lymphocytic, multifocal,
mild
Peyer’s patch – lymphoid hypoplasia, marked
2
Large intestine Lamina propria – colitis, diffuse, mild
3
Salivary gland NSL
3
Cervical l.n.
Lymphoid hypoplasia, moderate
3
Extraorbital
Adenitis, granulocytic and lymphocytic, multifocal,
lacrimal gland marked
4
Pancreas
Pancreatitis, lymphocytic, focal, minimal
Periarteritis, granulomatous, focal, moderate
4
Skin
Folliculitis, lymphocytic, focal, minimal
5
Spleen
Lymphoid hypoplasia, marked
EMH, marked
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
6
Lung
PB/PV, lymphocytic, multifocal, moderate
2620 - Liver
Triaditis, lymphocytic, multifocal, minimal
1
1
Kidney
NSL
2
Small intestine Lamina propria- enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch - NP
2
Large intestine Lamina propria - NSL
3
Salivary gland NSL
3
Cervical l.n.
NP
3
Extraorbital
NSL
lacrimal gland
4
Pancreas
Pancreatitis (periductal), lymphocytic, focal,
minimal
4
Skin
NSL
5
Spleen
Lymphoid hypoplasia, marked
EMH, moderate
5
Thymus
Hypoplasia, moderate, with no cortico-medullary
demarcation
Cyst
6
Lung
Eosinophilic macrophage pneumonia, focal,
moderate
2624 - Liver
Triaditis, lymphocytic, multifocal, minimal
1
1
Kidney
ISN, lymphocytic, multifocal, minimal
2
Small intestine Lamina propria- enteritis, lymphocytic, multifocal,
minimal
Peyer’s patch – lymphoid hypoplasia, marked
2
Large intestine Lamina propria - NSL
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PBS 12 2L

3

Salivary gland

PBS 12 2L
PBS 12 2L

3
3

PBS 12 2L
PBS 12 2L
PBS 12 2L

4
4
5

Cervical l.n.
Extraorbital
lacrimal gland
Pancreas
Skin
Spleen

PBS 12 2L

5

Thymus

PBS 12 2L

6

Lung

Adenitis, granulocytic and lymphocytic, focal,
minimal
NP
NSL
NSL
Perifolliculitis, lymphocytic, focal, minimal
Lymphoid hypoplasia, marked
EMH, moderate
Hypoplasia, marked, with no cortico-medullary
demarcation
PB/PV, lymphocytic, multifocal, minimal

Interpretation: Inflammatory infiltrates termed “lymphocytic” are
composed primarily of mononuclear cells admixed with small
numbers of granulocytes. The identity of the mononuclear cells as
lymphocytes should be verified by IHC.
Lymphocytes in these mice do not appear to be fully mature, as they
have large, poorly condensed nuclei.
Lesions termed “minimal” likely represent findings within normal
limits, and probably should not be counted as true lesions.
The eosinophilic macrophage pneumonia in mouse PBS 8 2R
is likely an incidental finding.
.
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